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 “Verily We created man from a product of wet earth; then placed him 
as a drop (of seed) in a safe lodging; then We fashioned the drop into a 
clot, then We fashioned the clot into a little lump, then We fashioned 
the little lump into bones, then clothed the bones with flesh, and then 
produced it another creation.” [23:12-14] 
 
Holy Quran, 14 centuries ago, long before any ultrasound machine existed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
ABSTRACT 
Studying the early germ cell development is of great significance, as germ cells transfer the 
genetic material between generations. However, in humans, this type of studies in vivo is not 
applicable, for obvious ethical reasons. Interestingly, differentiating human pluripotent stem 
cells (hPS cells) towards germ cells in vitro was recently reported. Therefore, studying 
differentiation of hPS cells towards germ cells is intriguing. On the other hand, due to the 
advancement in cancer therapy, the survival rates of the patients receiving chemotherapy and 
radiotherapy are improving dramatically. However, the improved survival rates increased the 
demand on fertility preservation, since most of the cancer treatments are gonadotoxic. In case 
of pubertal and post-pubertal male patients, semen cryopreservation offers a feasible and 
efficient option. Meanwhile, pre-pubertal patients do not have this option. Thus, finding an 
option for or such patients is absolutely encouraged. 
Hence, we aimed in this thesis at studying the early development and differentiation of the 
male germ cells in vitro, in order to find a robust protocol for fertility preservation for pre-
pubertal male patients. Specifically, we investigated whether the culture conditions and gene 
expression profile could be used to predict the differentiation potential of human embryonic  
stem (hES) cells towards male germ cells, tried to optimize the culture conditions for rat germ 
cell differentiation using a three-dimensional (3D) culture system, investigated the possibility 
of differentiating rat germ cells in vitro from immature testicular tissue, and studied the 
effects of long term in vitro culture on testicular tissues from pre-pubertal patients. 
We have found that undifferentiated hES cell lines exhibit different gene expression profiles. 
Furthermore, the suspension culture method resulted in downregulation of the pluripotency 
markers NANOG and POU5F1, compared to the culture on feeders. In addition, BMP7 
stimulation resulted in an upregulation in the germ cell markers KIT and DDX4 and somatic 
cell markers FSHR and HS3BD1. To study the optimal culture conditions for germ cell 
differentiation in vitro, rat testicular cells were cultured in a 3D culture system. We found that 
the choice of medium has an effect on Leydig cell functionality. In addition, the germ cells 
were migrating outwards the cell aggregations, making the conditions unfavorable for germ 
cell differentiation. Exploiting a reported method for murine germ cell differentiation in vitro 
to other species, we have obtained round spermatids expressing Crem and Acrosin (post-
meiotic markers) from rat undifferentiated spermatogonia, using the organ culture system and 
MEMα medium + 10% KSR. Interestingly, when we cultured human pre-pubertal testicular 
tissue for long term in vitro using an organ culture system, we have found that the Leydig and 
Sertoli cells showed viability and functionality for up to 42 days and 21 days respectively. 
In conclusion, we have assessed the effect of culture conditions on the differentiation 
potential of hES cells towards male germ cells in vitro. We have also investigated the culture 
conditions suitable for rat germ cell differentiation in vitro using a 3D culture system or an 
organ culture setup. In addition, we have also studied the effect of long term culture of human 
pre-pubertal testicular tissue in vitro.  
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1 INTRODUCTION 
Among multicellular organisms, the cell is considered the building block, where each cell 
type is specialized for a certain function. Germ cells are a unique type of cells, specialized in 
transferring the genetic material from one generation to the next. Based on that, the presence 
of healthy germ cells is extremely important for each organism to ensure passing its genetic 
material to the next generation. In humans, as they are not an exception, germ cells are the 
means by which humans can parent their own biological children. Hence, studying the germ 
cell development is of a great importance to humans. However, germ cell development 
begins at the early fetal life, which makes this type of studies in vivo extremely difficult, due 
to obvious ethical reasons. In order to study the early germ cell development in vivo, one 
option is to study other mammals (e.g. rats or mice) and extrapolate the observations to have 
an idea about the early germ cell development in humans. As an alternative, hES cells can be 
differentiated towards germ cells, allowing the researchers to study closely the early stages of 
germ cell development. 
On the other hand, germ cell differentiation in vitro is a promising tool that can help a lot of 
infertile people or people who are at high risk for infertility. However, understanding the 
spermatogenesis process in vivo is crucial to develop a robust system for in vitro germ cell 
differentiation. Therefore, germ cell differentiation in vivo will be discussed in details. 
1.1 HUMAN STEM CELL DERIVED GERM CELLS 
Notably, hES cells can differentiate into different cell lineages (1-4). One of the cell lineages 
they can differentiate to is the germ cell lineage. By differentiating hES cells towards germ 
cells, it gives us a unique opportunity to study the early germ cell development in humans. 
1.1.1 Human Pluripotent stem cells (hPS cells) 
The pluripotent term means the ability of a cell to give rise to other different cell types, while 
stem cell indicates the one-cell origin of different cell types (5). Thus, pluripotent stem cells 
are the cells that give rise to different types of cells. We will discuss here the origin, 
properties, and characterization of stem cells. 
1.1.1.1 Origin and potency of stem cells 
In mammals, after fertilization of the oocyte by a sperm, the zygote cell is formed. This 
zygote cell divides into 2, 4, 8, and 16 cells, which is called then the morula (6,7). Up to this 
stage, the cells are called balstomeres. Blastomeres are characterized at this stage by being 
totipotent, which means that they can give rise to the embryonic and the extraembryonic 
tissues (7). After 3 more cell divisions, the 128 cells formed are called blastula. In the blastula 
stage, the cells differentiate to give two different structures; an extraembryonic outer layer 
called trophoplast, and an inner mass of cells called inner cell mass (ICM). By this 
differentiation, the blastula is called blastocyst (7). The trophoplast cells will contribute to the 
placenta and will not contribute to the forming fetus, while the cells in the ICM are described 
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as pluripotent cells, which means that they can give rise to any of the cell types forming the 
fetus (8,9). Upon gastrulation, these cells differentiate to the three different germ layers 
(endoderm, mesoderm and ectoderm) which will form the fetus later. After this stage, the 
potent cells in the embryo can give rise to either many cell lineages, but not all cell lineages 
(multipotent) or to one cell lineage only (unipotent) (10). 
1.1.1.2 Properties of stem cells 
Pluripotent stem cells are characterized by two main properties; the ability to self-renew and 
the ability to differentiate towards the three different germ layers (endoderm, mesoderm and 
ectoderm) (1,11). Normal cells (non-stem cells) have a limited capacity of self-renewal. The 
chromosomes in these cells have terminal Deoxyribonucleic Acid (DNA) segments called 
telomeres. Upon DNA replication by DNA polymerases, each replication cycle implies 
deletion of DNA sequence from the telomeres, which means shorter chromosomes (12). In 
normal cells, this process can occur few times, after which the whole telomere is deleted and 
the chromosome starts to lose basic segments of its DNA. The normal cell cannot tolerate 
such loss, leading to cell death (13). On the contrary, pluripotent stem cells express uniquely 
an enzyme called telomerase. This enzyme is responsible for maintaining the telomere stable 
in each cell cycle, leading to a prolonged lifetime for the stem cells, implying so many cell 
divisions (12,14). 
Stem cells divide either by symmetric division or asymmetric division. In case replenishing 
of cells is needed, stem cells divide symmetrically to give two identical daughter stem cells. 
When stem cells are giving rise to other lineage, they divide asymmetrically to give one 
daughter stem cell and one daughter cell from the new cell lineage (15). 
1.1.1.3 Characterization of stem cells 
Discovery of the different sources of stem cells necessitated the characterization of these 
cells, in order to recognize them (16). This characterization is based on morphological basis, 
expression of specific cell markers, and differentiation potential in vivo and in vitro (17). 
Morphologically, hPS cells are characterized by high nucleus to cytoplasm ratio with a 
prominent nucleolus. When cultured in vitro, they form flat compact colonies with distinct 
borders (1,17). On the other hand, certain markers are expressed solely by hPS cells. These 
markers can be used to recognize stem cells from other types of cells. The markers include 
surface markers; such as stage-specific embryonic antigen 3 (SSEA3), SSEA4, tumor-related 
antigen (TRA)-1-60, TRA-1-81, and alkaline phosphatase (AP) (1,16,18), and transcription 
factors; such as POU class 5 homeobox 1 (POU5F1 or OCT4), NANOG and SRY (sex 
determining region Y) box 2 (SOX2), which are needed for pluripotency (16,19). As the cells 
become more differentiated, they lose the ability to differentiate towards different cell types 
and to self-renew (20). Hence, the expression of the pluripotency markers is inversely 
proportional with the expression of differentiation markers. The differentiation potential of 
stem cells can be evaluated in vivo and in vitro (21). The in vivo teratoma assay depends on 
the idea that injecting the stem cells into severe combined immune-deficient (SCID) mice 
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results in the formation of teratoma, which contains cells from the three germ layers 
(endoderm, mesoderm and ectoderm) (1). Meanwhile, the in vitro assay is based on the 
ability of stem cells to form spontaneously differentiated embryoid bodies (EBs), containing 
cells from the three germ layers (22). 
1.1.2 Sources of hPS cells 
There are three main sources of hPS cells; from embryos (embryonic stem cells, hES cells), 
from the adult tissues (adult or somatic stem cells), or by induction (human induced 
pluripotent stem cells, hiPS cells). Other sources include carcinoma stem cells (23), 
embryonic germ cells (hEG cells) (24), and umbilical cords stem cells (UCS cells) (25). 
The first embryonic stem (ES) cell line derived from mouse was reported in 1981 (11,26). 
Seventeen years later, the first human ES (hES) cell line was isolated. Using the leftover 
embryos from in vitro fertilization (IVF) clinics, cells from the ICM could be isolated, either 
mechanically or enzymatically, and placed in culture conditions supporting the 
undifferentiated state, as shown in Figure 1 (1,27). Nowadays, the advancement in the stem 
cell technology allowed researchers to derive hES cell lines from isolated single blastomeres 
at the morula stage (28,29). On the other hand, in each tissue of the adult or juvenile human 
body, there are some cells that are responsible for the regeneration of that tissue. These cells 
are called somatic (from the body tissues) or adult (could be found in the adult body) stem 
cells. They have the ability for self-renewal and the ability to differentiate towards a limited 
number of cell lineages in vivo, depending on the tissue (30,31). However, the plasticity of 
these cells increases in vitro and they become able to differentiate towards many cell 
lineages, even if they do not share the same germ layer (32-34). The importance of the adult 
stem cells as a clinical tool arises from the fact that they are much less controversial ethically 
than hES cells to use. Examples of the adult stem cells include the hemopoietic stem cells 
(35), the mesenchymal stem cells (MSCs) (36), the neural stem cells (37), and the 
spermatogonial stem cells (SSCs) (38,39). 
Another source for hPS cells is the hiPS cells. By this technique, the normal somatic cells are 
induced by forcing the expression of certain pluripotency genes to become pluripotent. The 
first iPS cells produced from mouse fibroblasts was reported in 2006, by the forced 
expression of four transcription factors; Pou5f1, Sox2, Krueppel-like factor 4 (Klf4), and v-
Myc myelocytomatosis avian viral oncogene homolog (c-Myc) (40). One year later, the first 
iPS cell line was produced from human fibroblasts, using the same four factors (41). 
Meanwhile, another group has reported similar success with different transcription factors 
(POU5F1, SOX2, LIN28 and NANOG) (42). In these reports, they used retroviral and 
lentiviral transfection as a method of inducing the pluripotency gene expression. However, 
this method implies the risk of genomic instability, due to the integration of exogenous genes 
(43). Thus, the use of non-integrating viral vectors (Sendai virus) and episomal plasmids are 
becoming more popular (44,45), as they do not imply integration of exogenous DNA. 
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Recently, the production of hiPS cells by somatic cell nuclear transfer (SCNT) has been 
reported as well (46). Moreover, using proteins and messenger Ribonucleic Acid (mRNA) 
directly to produce hiPS cells has been also reported (47,48). Another problem facing the 
clinical use is using a feeder-free culture condition to derive hiPS cells. However, it was 
possible to achieve such derivation using Matrigel and fibronectin, albeit not xeno-free (49-
52). Although the production of hiPS cells in xeno-free conditions on laminin was recently 
reported (53), it is still a challenge to derive hiPS cells in a combination of feeder-free, xeno-
free, chemically defined, and integration-free conditions. 
 
 
Figure 1. The embryonic stem (ES) cells. The zygote is formed when a sperm fertilizes an oocyte. This 
zygote (one cell) develops to the morula (16 cells) which develops to the blastocyst. The ES cells are 
derived by isolating the inner cell mass (ICM) from blastocysts. The ES cells have the differentiation 
potential towards the three germ layers; ectoderm, mesoderm, and endoderm, as well as the germ line. 
 
1.1.3 Culture conditions for hPS cells 
As discussed earlier, hES cells are undifferentiated cells that are not specialized for any 
specific function. They can differentiate towards any cell lineage from the three germ layers. 
Hence, when the hES cells cultured in vitro, they need to be kept under certain conditions that 
allow their propagation but inhibit their differentiation. It has been shown that hES cells need 
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basic fibroblast growth factor (FGF2) to keep their pluripotency, through the 
Phosphatidylinositol-3-Kinase and Protein Kinase B (PI3K-AKT) and MEK (MAPK 
(Mitogen-activated protein kinase)/Erk kinase)-ERK (Extracellular signal-regulated kinase) 
pathways (54-59). Moreover, Transforming growth factor β (TGFβ) signaling through the 
Contraction of Sma and Mad (Mothers against decapentaplegic) SMAD2,3 is also required to 
maintain the pluripotency of the hES cells (60,61). The first hES cell line was derived on a 
mouse embryonic fibroblast (MEF) feeder layer using serum conditioned medium. The 
feeder layer was essential to support the attachment of the cells and the maintenance of 
pluripotency for the hES cells, by providing FGF2 and TGFβ1 (1). However, the serum can 
vary from one batch to another, and as the animal-derived component can have the risk of 
viral contamination. Besides, if the clinical use is intended, the culture condition should be 
chemically defined and xeno-free as much as possible (62). Recently, researchers aim at 
finding the optimal culture conditions to keep the hES cells undifferentiated in culture using 
feeder-free, xeno-free, serum-free, and chemically defined medium. In that context, the 
mouse fibroblast could be replaced by human feeder cell layer, in order to minimize the 
animal-derived substances in the culture (63-65). Later on, the feeder layer could be replaced 
by Matrigel, which is a mouse tumor extract, fibronectin and laminin (66-69), and the serum 
has been replaced by knockout serum replacement (KSR) (70,71). In another attempt to keep 
the hES cells undifferentiated in a feeder-free culture, the suspension method, which implies 
culturing of the hES cells in cell aggregates in low-adhesion plates, has been reported (72). 
The passage of the hES cells can be performed enzymatically (e.g. collagenase and trypsin) 
or mechanically (1,64,73). Both methods showed a very similar genomic profile for the hES 
cells after passaging (74). However, hES cells tend to have a poor survival after dissociation 
into single-cell level (75). This survival was much improved using Rho-associated coiled-coil 
kinase inhibitor (ROCKi) in the culture medium (76,77). Using laminin-521/E-cadherin and 
xeno-free Nutristem medium, it was possible to dissociate the hES cells to a single cell level 
with improved survival, without using ROCKi (28). In addition, it has been reported that 3D 
culture system was used successfully to culture hES cells (78-80). The 3D culture system in 
these studies helped the ES cells to form vascular structure, epithelial structure and insulin-
producing islets, as these structures necessitate a spatial support to be formed. 
The accumulating evidences are indicating that the hES cells resemble more the epiblast 
derived mouse stem cells (mEpiS cells) in culture requirements and gene expression profile 
than the mouse ES cells (mES cells) (81). Therefore, it is believed that there are two 
developmental states of stem cells; naïve (mES cells) and primed (mEpiS cells and hES cells) 
(61). The naïve state of mES cells requires Leukemia Inhibitory Factor (LIF) signaling and 
dual inhibition of MAPK/Erk kinase (MEK) and glycogen synthase kinase (GSK3) (82). 
Hence, mEpiS cells could be converted into mES cells using this dual inhibition (2i) (83-86). 
Since then, many researchers tend now to get the hES cells into the naïve state first prior to 
differentiation, using the (2i/LIF) culture conditions (87-92). However, this naïve state of the 
hES cells needs to be more characterized. 
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1.1.4 Differentiation potential of hPS cells 
hPS cells can differentiate towards various cell lineages which enables them to be a 
prospective clinical tool in regenerative medicine. Depending on the culture conditions, 
researchers could differentiate hPS cells towards different cell lineages, as shown in Figure 1. 
However, it has been reported that the different hPS cell lines exhibit different gene 
expression profiles and hence different potentialities to differentiate towards the different cell 
lineages (16,93). Recently, hPS cells have been differentiated successfully towards neural 
cells (94,95), cardio muscular cells (96-98), hepatocytes (99), prostate cells (100), insulin-
producing endocrine cells (101,102), and retinal epithelial cells (103). The source of the hPS 
cells is crucial to the application they are intended to be used for. Although hES cells are 
easily derived compared to the hiPS cells, however, the ethical issues and the risk for 
immune-rejection related to the hES cells makes hiPS cells more prone to clinical use. 
Nonetheless, generating hiPS cells takes a lot of time and effort. Moreover, it implies 
sometimes (depending on the transfection method) a risk for gene insertion or deletion due to 
exogenous DNA integration, which makes the use of hiPS cells still not fully exploited. 
Besides, the produced hiPS cells could retain some epigenetic modifications from its original 
somatic state (104). In that context, using the adult or somatic stem cells (e.g. hemopoietic 
stem cells, MSCs, and SSCs) as a clinical option is a promising strategy. They can be used 
directly as multipotent cells (e.g. hemopoietic stem cells) (105), de-differentiated first to more 
naïve stage by culturing in vitro and utilize them later as pluripotent cells (e.g. SSCs) 
(106,107), or transdifferentiate them to another cell lineage directly (e.g. SSCs (39) and 
MSCs (36)). 
1.1.5 Differentiation of hPS cells towards male germ cells 
The main aim for differentiating hPS cells towards male germ cells is to study the early 
human germ cell development. However, another aspect is to model human male infertility in 
vitro. Many groups have reported that hES cells differentiated towards male germ cells (108-
114). In addition, others have reported similar results using hiPS cells (115-117). However, 
the efficiency of such method was very poor, making the improvement of such protocol 
inevitable. One of the important growth factors, Bone Morphogenetic Protein 4 (BMP4), has 
been reported to induce the differentiation of hPS cells towards the male germ cell lineage 
(108,113,118). Moreover, V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene-Like 
Protein (KIT) signaling and Wingless-type MMTV integration site family member 3 A 
(WNT3A) signaling were shown to induce this differentiation (108,118). It has been also 
reported that overexpression of the Deleted in azoospermia (DAZ) family genes, DEAD Box 
Protein 4 (DDX4) and Deleted in azoospermia-like (DAZL) induce the production of haploid 
cells from hPS cells (116,119,120). One more factor found to induce the differentiation was 
the Retinoic Acid (RA) (121). However, more recent protocols are available now to for 
differentiation of hPS cells towards male germ cells (122,123). The culture conditions used in 
such differentiation varied from utilizing feeder fibroblast layer (108,110,122) to EBs 
formation (112,120). 
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As mentioned earlier, hES cells resemble more the mEpiS cells (primed state) rather than the 
mES cells (naïve state). Knowing that the differentiation potential of mEpiS cells towards the 
germ cell lineage is less than the mES cells, it has been suggested that culturing the hES cells 
in a more naïve state would allow them to differentiate towards the germ cell lineage (124). 
Using four kinases inhibition (MAPK, GSK3, p38, and c-Jun N-terminal kinase [JNK]), it 
was possible to culture hPS cells under naïve state (90). These four kinases inhibition enabled 
one group to differentiate hPS cells under the naïve conditions towards human primordial 
germ cell (PGC)-like cells (hPGCLCs) with much improved efficiency (125). In another 
report, hiPS cells were differentiated towards hPGCLCs with similar efficiency while 
cultured in primed state (126). 
Moreover, it has been shown that ES cells and iPS cells can differentiate in vitro to germ cell 
(127,128). These in vitro produced germ cells have been reported to differentiate to haploid 
cells in culture, which could be thought of as a clinical option for infertile males with Sertoli 
cell only syndrome (SCOS) (115,116). The putative germ cells produced by hPS cells 
differentiation could be isolated by different surface markers, such as glial cell line-derived 
neurotrophic factor family receptor-α1 (GFRα1), KIT, and TRA-1-81. However, these 
markers are not germ cell specific, which makes the use of other intracellular markers 
(e.g.DDX4) more appropriate (120). Besides, it has been recently reported that hPS cells 
could be differentiated towards haploid post-meiotic cells, though in a small population of 
cells (117-120,122,123,129). In these reports, DNA content analysis was performed using 
flow cytometry, along with examining the protein expression of some post meiotic markers; 
e.g. ACROSIN and PROTAMINE 1. 
1.1.6 Molecular basis for stem cells differentiation to germ cells 
In the undifferentiated pluripotent state, hPS cells express the pluripotency related genes, 
such as POU5F1, SOX2, and NANOG. Upon differentiation, the pluripotency genes are 
generally downregulated, while the differentiation and development genes are upregulated. 
However, when it comes to the germ cell lineage, this might not be the case. The early stages 
of germ cell development share the expression of some pluripotency related genes (e.g. 
POU5F1) with stem cells. Thus, the downregulation of such genes is not expected to coincide 
with the differentiation of hPS cells towards the germ cell lineage. However, SOX2 was 
shown to be downregulated by the BMP4 signaling during the human germ cell specification 
(126,130). This comes in contrast to the mouse model, where Sox2 is essential for the mouse 
germ cell specification and development (131-133). Another difference to the mouse model is 
the role of SOX17 in human germ cell specification. Recently, SOX17, a known marker for 
endoderm development (134), has been shown to be essential for human germ cell 
specification (125). In the same context, B lymphocyte-induced maturation protein 1; 
BLIMP1 (also known as positive regulatory domain zinc finger protein 1; PRDM1), which is 
a downstream of SOX17, was shown to stabilize the genes related to the germ cell lineage 
specification and to repress the neural differentiation (126). BLIMP1 was also reported to 
inhibit the mesoderm and endoderm development (125). 
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On the other hand, FGF2 stimulates its receptor in the hPS cells undifferentiated state and the 
downstream MAPK-AKT and PI3K-AKT pathways, which inhibits the BMP signaling 
pathway and hence the differentiation (56,135). Then, upon stimulation with BMPs, 
differentiation of the cells is induced through the activation of the SMAD signaling (136). A 
member of the TGFβ family, ACTIVIN, was found to be important, along with NODAl, for 
self-renewal of the hPS cells (58,137). However, the NODAL/ACTIVIN pathway was shown 
to be important in the early PGCs development, as it ensures maintaining the cells 
undifferentiated, hence, not entering meiosis (138-140). 
1.1.7 Ethical issues related to hPS cells 
The ethical controversy of hPS cells usage in medicine and research depends on a great extent 
on the source of these stem cells, rather than the intended use itself. In case of hES cells, their 
derivation from the human embryos brings them to the frontline of this controversy. While 
the derivation of these cells is restricted in research to leftover embryos from IVF clinics at 
the first12 weeks of gestation, the ethical dilemma arises from the debate about whether to 
consider the embryo as a human being from the first day of conception or after a certain 
period of development (e.g. 120 days), in other words, it is about when life actually starts 
(141). The opposing argument for stem cell use is usually associated with the religious and 
ethical debate opposing abortion. In the USA, it was banned in 2001 to derive novel hES cell 
lines, despite accepting the already existing ones as a response for this controversy. However, 
no such limitations were imposed in the majority of the European countries (142). On the 
other hand, usage of the adult (or somatic) stem cells in medicine and research is not of a big 
controversy like the hES cells, as they can be derived from the body without any loss of life 
(143). Similarly, usage of the hiPS cells in clinical use can be considered much less 
controversial than hES cells, as their derivation does not imply destruction of any human 
embryos (141). However, for research purposes, ethical issue could evoke regarding the use 
of such cells in certain uses without consent from the donor, which would break the donor’s 
confidentiality (144). This issue can be avoided by the proper consent from the donor. One 
more option to produce human pluripotent cells is by SCNT. The ethical issues related to 
such technique are even more controversial, starting from the creation of human embryo for 
the sake of research, passing through the usage of the SCNT technique per se, and maybe 
ending with the use of animal oocytes with human nuclei to produce the embryos (141,145). 
Another issue to add to the ethical burden in this thesis was the usage of such stem cells to 
produce germ cells. These germ cells, once produced, could be used later in producing human 
beings, which would be of a great controversy. However, the main aim of germ cell 
derivation from hES cells was to study the early germ cell development, which implies the 
restriction to the early stages only, with no intention of using the produced germ cell in 
producing human beings. Moreover, not similar to the use of stem cells in clinical trial, 
producing germ cells does not include introduction of stem cells in the human body, which 
can imply some risk for the patient (141,146). 
  9 
From one perspective, deriving the hES cells from the leftover embryos at IVF clinics is the 
important point. As the produced embryos need to be destroyed if not used for clinical 
purpose, it would be a waste to lose such material and not using it in research, especially if 
the production of a human being is not intended with this research. The usage of hES cells is 
of great importance in research, as it provides us with an unlimited supply of information 
about the early stages of development. Hence, it could be considered that using hES cells in 
research is acceptable ethically; based on the current method of derivation and the benefits 
and uses they are exploited for. 
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1.2 TESTIS 
In mammalian males, the testis is a unique specialized organ characterized by the ability to 
produce androgens and gametes. These gametes are capable of transferring the genetic 
material to the next generation. Herein, we will discuss the structure, morphology and origin 
of testis in human and rodents, along with the germ cell development. 
1.2.1 Structure and morphology 
In human and rodents, the testes are found in the scrotum, which is located under the penis 
and formed of smooth muscles and skin. The function of the scrotum is to give about 2-3°C 
lower to the testes than the body temperature, which is 37°C. This lower temperature is 
important for proper spermatogenesis (147). The size of a healthy human testis ranges from 
12 to 30 ml, with an average of 18 ml. Measuring the testis size is performed either by the 
orchidometer or by ultrasound measuring, which is proven to be more accurate (148). In rats, 
the average of testis size is about 18 ml, which is quite large in relation to the size of the body 
when compared to other species (149,150). 
In all mammals, each testis is an oval structure composed of convoluted seminiferous tubules 
wrapped in a connective tissue sheath called tunica albuginea. This sheath makes some 
invaginations in the testis, forming lobules. Meanwhile, the seminiferous tubules divide the 
testis into two compartments; the intra-tubular compartment and the interstitial compartment. 
The intra-tubular compartment contains the germ cells, Sertoli cells lying on the basement 
membrane, and peritubular myoid cells (PMCs) surrounding the tubules, while the interstitial 
compartment contains Leydig cells, immune cells, blood vessels, and connective tissue (as 
shown in Figure 2). Within the seminiferous tubules, tight junctions between the Sertoli cells 
form the blood testis barrier (BTB). This BTB is responsible for protecting the haploid germ 
cells in the intra-tubular compartment from the immune system (151). The germ cells are 
differentiated in the seminiferous tubules, giving rise eventually to haploid cells called 
spermatozoa. These spermatozoa travel through the seminiferous tubules to the rete testis and 
then through the efferent ducts to the epididymis, where they get fully matured. The 
epididymis is formed mainly of three parts; the head (caput), the body (corpus) and the tail 
(cauda). The main function of the epididymis is to get mature the spermatozoa by gaining the 
ability to move and fertilize, while being kept in the tail of the epididymis. Afterwards, sperm 
pass through the vas deferens to the seminal vesicle, where they are stored till ejaculation 
through the urethra (152). 
1.2.2 Origin and development 
Due to the scarcity of the human material at the very early embryonic stages, most of the 
knowledge available about the testis development in humans is extrapolated from studying 
this development in other species (e.g. rodents). In mammals, the testis is derived from the 
mesoderm as an undifferentiated gonad, which has the potential to develop towards both 
types of gonads; testis and ovary. However, the decision to differentiate towards a specific 
type of gonad is pre-determined from the moment of fertilization, using the XY specification 
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model (XY for testis and XX for ovary). In other words, the expression of the SRY gene 
(located on the Y chromosome) is responsible for the sex determination (153). 
In humans, the SRY expression begins at week 6 of gestation, leading to the expression of 
SOX9 in some cells at the genital ridge. The SOX9 expression results in the differentiation of 
these cells to immature Sertoli cells, through the FGF9 signaling pathway (154). These 
immature Sertoli cells produce then the Anti-Müllerian hormone (AMH) which is responsible 
for the regression and degeneration of the Müllerian duct. The other mesenchymal cells in the 
differentiating gonad develop, due to the SOX9 expression in the differentiating Sertoli cells, 
to PMCs and fetal Leydig cells. The fetal Leydig cells produce testosterone, resulting in the 
development of the Wolffian duct, and dihydrotestosterone, resulting in the development of 
the external genitalia. However, the fetal Leydig cells persist in humans till the age of 6 
months postnatally, afterwards, they disappear. Around puberty, the adult Leydig cells 
emerge once more, resuming the testosterone production (Figure 2). Hence, there is a peak of 
serum testosterone level around birth and up to 6 months of age, during which the descending 
of the testes into the scrotum takes place, followed by a quiescent period till puberty, where 
the testosterone levels rise once more (155,156). Meanwhile, descending of the testis into the 
scrotum takes place by the 7
th
 month of gestation or shortly before birth. In the differentiating 
gonad, the Sertoli cells aggregate with the PGCs, originating from outside the gonad, to form 
the testis cords, which are the precursors for the seminiferous tubules. The appearance of the 
testis cords at gestational week 7-8 is the first sign of the gonadal differentiation towards a 
testis (153,157). Regarding the immature Sertoli cells, they have two phases of proliferation 
in humans; the first starts from fetal life till the first year postnatally, and the second starts 
before puberty and persist till the age of 15 years (158,159). This proliferation is under the 
control of the gonadotropin; follicle stimulating hormone (FSH), while the maturation is 
stimulated by the presence of thyroid hormone (158). Sertoli cell proliferation is an important 
step, as the total number of Sertoli cells is quite relevant to the number of germ cells they can 
nurse, leading to a relevant number of sperm the testis can produce after puberty (160). 
Around 15 years of age, Sertoli cells stop proliferating and start showing evidences of 
maturation (Figure 2); such as the changes in morphology (polarization and tri-forked nuclei), 
secretion of Inhibin B, and expression of certain maturation markers (e.g. P27
KIP1
) (158). 
In the rat, the Sry expression starts around 11.5 days post coitum (dpc) for one day and then 
shuts off, in contrary to the situation in humans where this expression persists. However, the 
cascade of events following the Sry expression is quite similar in both species. The Sry 
expression stimulates the expression of Sox9, resulting in the testis cord formation around 
13.5 dpc. These testis cords are formed of the migrating PGCs and the immature Sertoli cells 
(161). Postnatally, the rat testis differs from the human testis in the time frame they develop 
through. While in humans there is a lag phase between the neonatal period and puberty, these 
two overlap in the rat, leading to a continuous development with no quiescent period 
(158,162-164). The rat fetal Leydig cells increase in number at the first week postnatally, 
followed by the proliferation of the adult Leydig cells precursors, which differentiate to the 
mature adult Leydig cells eventually around puberty or 60 days postpartum (dpp) (165,166). 
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Once fully matured, the adult Leydig cells stop proliferating (167). As for the immature 
Sertoli cells, they start proliferating in the fetal life without interruption and quit only around 
15-21 days postnatally, where they become mature (Figure 2). Coincident with this 
maturation is the formation of the BTB as tight junctions between the Sertoli cells (158,166). 
 
 
Figure 2. Pre-pubertal and post-pubertal testis. A transverse section of a pre-pubertal testis shows a 
testis cord surrounded by immature peritubular myoid cells (PMCs) and fetal Leydig cells in the 
interstitial tissue. The testis cord contains gonocytes in the middle, spermatogonial stem cells (SSCs) 
on the basement membrane, immature Sertoli cells and a few differentiating Sertoli cells. On the other 
side, a transverse section in a post-pubertal testis shows a seminiferous tubule surrounded by mature 
PMCs and adult Leydig cells in the interstitial tissue. The seminiferous tubule contains mature 
polarized Sertoli cells on the basement membrane and germ cells at different stages of development; 
SSCs on the basement membrane, spermatocytes, spermatids, and spermatozoa in the luminal 
compartment. The bottom of the figure shows the development of the somatic cells from immature to 
mature cells (Sertoli and Leydig cells) and the different developmental stages of the germ cells 
(gonocytes, SSCs, spermatogonia, spermatocytes, spermatids, and spermatozoa). 
 
 
1.2.3 Germ cell development 
In humans, PGCs, which are the precursors for germ cells, are specified during the week 3-4 
of gestation at the junction between the allantois and the yolk sac outside the developing 
gonad, in response to BMPs signaling (168,169). The BMP signaling stimulates the 
expression of PRDM14 and PRDM1 (also known as BLIMP1), which in turns stimulates the 
expression of AP-2 gamma. The expression of these three gens is important for germ cell 
specification process (130,170-173). These PGCs are characterized by being round large cells 
with round nucleus positive for AP (174,175). At week 5 of gestation, they start migration 
from the hindgut through the dorsal mesentery till they reach their destination at the genital 
ridge (which is still undifferentiated gonad yet) by the end of the 6
th
 week of gestation (176-
180). This migration is thought to be through passive and active movements under the control 
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of the KIT signaling, as the migrating PGCs express the KIT receptor (178,181-184). During 
their migration and after colonization till gestational week 9, the PGCs proliferate in number 
from about 1000 to 150 000 cell (157). However, the PGCs are still bi-potential till this step; 
they can differentiate to either male or female germ cells, depending on the signaling from 
the somatic cells in the differentiating gonad (185). Once the PGCs are enclosed inside the 
testis cords with the immature Sertoli cells they are called gonocytes, where they are located 
at the center of the cords (157,186,187). These gonocytes remain mitotically active, even 
after the sex determination decision on the germ cell level around 11-12 weeks of gestation. 
This sex determination decision to the male side is mediated through FGF9 signaling and RA 
inhibition, both of which inhibit the cells from entering meiosis (185,187,188). However, 
they stop proliferation in the third trimester and erasure of the DNA methylation occurs 
(189,190). Then, they enter mitotic arrest at G0 till after birth, where they resume their 
proliferation till 6 months of age postnatally (191). At this age, they start to reside on the 
basement membrane and change morphologically and on gene expression level to what we 
call SSCs (Figure 2) (157). These SSCs stop expressing the pluripotency genes expressed 
earlier by the gonocytes; such as POU5F1, NANOG, Transcription factor AP-2 gamma 
(TFAP2C) and KIT (192). 
In the rodents, a very similar process of germ cell specification takes place, with a different 
time frame. The specification of the PGCs starts at 6.25 dpc (168,169). Around 40 cells 
positive for AP are recognized at the yolk sac junction with the allantois at 7.25 dpc, which 
are identified as PGCs (174-176). At the age of 8.5 dpc, the PGCs start migrating towards the 
genital ridge, where they colonize before the age of 11.5 dpc (178). The sex cords are formed 
around 13.5 dpc, and the PGCs are called then gonocytes, located at the center of the cords 
(193). These gonocytes remain mitotically active for 2-3 days after colonization, followed by 
mitotic arrest at G0 till birth, where they resume their proliferation at 4 dpp (194). 
Meanwhile, they start heading to the basement membrane where they reside and hence called 
SSCs around 4-6 dpp (Figure 2) (193). In contrast to the situation in humans, the SSCs in 
rodents do not lose their expression of the pluripotency markers; such as Pou5f1, Nanog, 
Tfap2c and Kit (171,195-197). 
Nevertheless, the germ cells are characterized by the presence of some unique RNA binding 
proteins (RBPs). These RBPs can be used as markers for germ cells through the different 
stages of development (198,199). For instance, NANOS2 is expressed in humans from week 
14 of gestation in the gonocytes, while in the adult testis it is expressed in the spermatogonia 
and some spermatocytes and round spermatids (200,201). Besides, Nanos2 is expressed in the 
rodents at 13.5 - 17.5 dpc and in the adult testis in the SSCs (202,203). The function of 
NANOS2 is thought to be inhibiting the entrance to meiosis by suppressing Stimulated by 
retinoic acid gene 8 (STRA8), DAZL, and synaptonemal complex protein 3 (SYCP3) 
(203,204). In addition, NANOS3 is expressed in the fetal testis at around 8 weeks of gestation 
in the gonocytes and continues to be expressed in the adult testis the spermatogonia, 
spermatocytes, and round spermatids (200,205,206). In the rodents, Nanos3 is expressed in 
the fetal testis from 7.35 dpc in the PGCs and in the adult testis in the undifferentiated 
 14 
spermatogonia (207,208). The suggested role of NANOS3 is to suppress apoptosis in the 
migrating PGCs (209,210) and to maintain the SSCs population postnatally (207,208). 
Other examples for the germ cell specific RBPs include DAZL, BOULE and DDX4. Both 
DAZL and BOULE are members of the DAZ (deleted in azoospermia) gene family. BOULE is 
expressed in the germ cells at the meiotic phase (211). Meanwhile, DAZL is expressed in the 
germ cells from the fetal life in the first trimester and throughout the adult life in 
spermatogonia, spermatocytes and post-meiotic cells (211-215). The possible role of DAZL 
is to bind to DDX4 and SYCP3 to promote their translation (216,217). In addition, DDX4 is 
expressed in humans in the migratory PGCs after 7 weeks of gestations and continues in the 
adult life in the spermatogonia, spermatocytes and spermatids (214,218,219). Although 
DDX4 is essential for spermatogenesis, its exact role still needs to be elucidated (219). In 
rodents, Boule, Dazl, and Ddx4 have a very similar expression pattern to humans. Dazl is 
expressed in the migratory PGCs in the fetal testis and continues to be expressed exclusively 
in the adult testis in the germ cells (211,213,220-222). Meanwhile, Ddx4 is expressed in the 
fetal testis at 11.5 dpc in the PGCs and continues to be expressed exclusively in the germ 
cells in the adult testis (223,224). 
 
 
 
  
  15 
1.3 SPERMATOGENESIS 
Spermatogenesis is the process by which diploid SSCs differentiate to haploid spermatozoa. 
This process is a complex process occurs in vivo in the testis, necessitating a lot of factors and 
cues both intrinsically and extrinsically (225). In this section, stages and the cycle of 
spermatogenesis will be discussed, along with the somatic cell environment and hormonal 
control of spermatogenesis. 
1.3.1 Stages 
In mammals, the same three stages of spermatogenesis are conserved; spermatocytogenesis, 
spermatidogenesis, and spermiogenesis. The whole spermatogenesis process takes about 74 
days in humans (226) and 56 days in rats (152,227). It starts around puberty in humans and at 
9 dpp in rats (228). However, production of spermatozoa in rats is only evident around 
puberty. Starting from puberty, production of spermatozoa continues throughout the whole 
adult life, although it tends to decline while the age advances (229). 
1.3.1.1 Spermatocytogenesis (the mitotic phase) 
It is the process by which the spermatogonia proliferate and mitotically divide to give 
primary spermatocytes (Figure 2). Interestingly, there is no known specific marker for SSCs 
so far. However, in an attempt to find a marker for the SSCs, there are some suggested 
markers, which included Zinc Finger And BTB Domain Containing 16 (ZBTB16), Ubiquitin 
C-Terminal Hydrolase L1 (UCHL1), and GFRA1 (187,230,231). 
In humans, there are two types of undifferentiated spermatogonia; Adark and Apale 
spermatogonia. These terms are based on the difference in the intensity of the nucleus when 
stained with hematoxylin (232). The Adark spermatogonia are quiescent and do not usually 
undergo any mitosis, unless there is some kind of injury to the testis. Hence they are known 
as the reserve spermatogonia or the real stem cells (233). Meanwhile, Apale spermatogonia 
divide mitotically to give a self-renewed cell and type B spermatogonia. These B 
spermatogonia divide mitotically to give two primary spermatocytes which enter meiosis 
(234). Due to the limited number of replication prior to meiosis in humans, the total number 
of spermatozoa obtained from one SSC cannot exceed 32, which is extremely low compared 
to the situation in rodents where the number of spermatozoa can reach thousands (235). 
In rodents, the undifferentiated spermatogonia include Asingle, Apaired, and Aaligned 
spermatogonia. Meanwhile, the differentiating spermatogonia include 4 types of A 
spermatogonia (A1-A4), one type of Intermediate spermatogonia (Int) and one type of B 
spermatogonia (236). The Asingle spermatgonia divide to give two Apaired cells. These cells 
divide to give 4-16 cells of Aaligned cells. The division goes on to give the A1-A4 
spermatogonia, Int spermatogonia and B spermatogonia. The B spermatogonia divide to give 
primary spermatocytes (152,228). 
 16 
It is worth mentioning that physiological apoptosis of spermatogonia is a part of the normal 
regulatory mechanism of spermatogenesis (237,238). Increased or reduced apoptotic activity 
results in impaired spermatogenesis (239,240). 
1.3.1.2 Spermatidogenesis (the meiotic phase) 
In this stage, each diploid primary spermatocyte divides by meiosis to give four haploid 
spermatids (Figure 2). In humans and rodents, the process is quite similar. First, the primary 
spermatocyte undergoes one round of DNA replication in the pre-leptotene phase (before 
entering the prophase I of the first meiosis or meiosis I). Then, it enters the prophase I, which 
is formed of 4 subsequent steps; leptotene (where the meiosis proteins attach to the 
chromosomes), zygotene (where the chromosomes are paired), pachytene (where the 
crossover and recombination of DNA take place), and diplotene (where the chromosomes 
separate from each other). This stage (prophase I) takes the longest time in meiosis, which 
lasts 24 days in humans, 18 days in rats, and 12 days in mice (152,227,241). Later on, the cell 
finishes meiosis I, enters prophase II and finishes meiosis II within 1-2 days, forming the 
haploid round spermatids (234,242). 
One of the markers that can be used to show if the germ cells have entered meiosis is the 
SYCP3 protein. The SYCP3 and SYCP2 bind to a pair of homologous chromatids in the 
leptotene phase. In the zygotene phase, the two chromatids attach to each other by the SYCP1 
protein (243). The crossover between the two homologous chromatids takes place in the 
pachytene phase, followed by degradation of the synaptonemal complex (SC) protein in the 
diplotene phase (244). Another marker for the late meiotic stage is the cyclic adenosine 
monophosphate (cAMP) responsive element modulator (CREM) protein. The CREM protein 
is expressed in mammalian male germ cells mainly from the late pachytene spermatocyte 
stage and on. However, it has more than one isoform; the repressor form is expressed and 
dominates in the early pre-meiotic stage, while the activator form is expressed and dominates 
in the meiotic stage. Generally, it is highly expressed in the meiotic stage compared to the 
early pre-meiotic stage, and that is why it is mainly detected in the late meiotic stage. 
Nevertheless, CREM has a pivotal role in activating the genes that encode structural proteins 
needed for spermatozoa differentiation (245-247). 
1.3.1.3 Spermiogenesis (the post-meiotic phase) 
During this stage in mammals, the haploid round spermatids produced by meiosis 
differentiate to the mature spermatozoa with no change in the number of cells (226). 
However, there is a dramatic change in morphology that takes place in four steps (Figure 2) 
(234). First, in the Golgi phase, the proacrosomal granules are formed and attached to one 
pole of the nucleus. Second, in the cap phase, the acrosomal granules aggregate, fuse and 
form the acrosomal cap, while the cell becomes more elongated. Third, in the acrosomal 
phase, the histone proteins are replaced by protamine in the nucleus, which becomes more 
condensed. Meanwhile, the flagellum starts to mature and be visible. And finally, in the 
maturation phase, the cytoplasm shrinks in volume, due to the extrusion of residual bodies, 
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which are phagocytosed by the Sertoli cells (242,248). Once the spermatozoa are mature, 
they are released to the lumen. Then they move by the seminiferous tubule contractions to the 
epididymis, where they get fully matured by gaining the ability to swim and fertilize the 
female gametes (249). 
The markers used usually to recognize the germ cells in the post-meiotic stage include 
Protamine 1 (PRM1) and ACROSIN. The protein PRM1 is one of two forms of protamine 
(PRM1 and PRM2) that replaces the histone proteins in the chromatin during spermiogenesis 
in the maturing spermatozoa. In mice and humans, the two forms of protamine (PRM1 and 
PRM2) are present (250). However, in rats, only one form of protamine (Prm1) is present, 
even though the Prm2 gene is available, due to inefficient transcription (251). ACROSIN, 
which is a serine protease in the acrosome of the post-meiotic haploid male germ cells, is 
expressed as an inactive zymogen, proacrosin. Hence, it is stored in the acrosome till it is 
needed in fertilization (252,253). ACROSIN is co-existent in the acrosome with another 
enzyme important for fertilization, which is the hyaluronidase enzyme. While hyaluronidase 
is important to disperse the cumulus oophorus (a cluster of cells surrounding the oocyte), 
ACROSIN is important to penetrate the zona pellucida (a glycoprotein layer surrounding the 
oocyte between the oocyte and the cumulus oophorus) (254-256). However, it was reported 
that ACROSIN is not essential for fertilization, in humans (257) or in mice (258). In rats, the 
Acr (acrosin) gene is transcribed in the diploid stage, while it stays under translational control 
to be first seen at protein level in the post-meiotic haploid round spermatid stage (252,254). 
1.3.2 Spermatogenic cycle 
In the adult mammalian testis, spermatogenesis process through the seminiferous tubules 
actually resembles a wave. When a germ cell advances in development, it gets closer to the 
lumen and further from the basement membrane. Hence, at any point of the seminiferous 
tubule, there is more than one germ cell above each other in different stages of development. 
Interestingly, these germ cells develop together in a synchronized pattern. These 
synchronized patterns are found in sequence along the seminiferous tubule, making the 
development through the seminiferous tubule look like a wave (259). Thus, the different 
germ cells from different developmental stages are locked together in one tubular stage. This 
tubular stage (which is a group of developmental stages) is repeated along the seminiferous 
tubule every certain number of tubular stages in a cyclic pattern, which makes the stages 
looks more like a cycle. This cycle is called ‘the spermatogenic cycle’. The length of the 
spermatogenic cycle and the number of stages in the cycle is characteristic for each species 
(260-262). Many researchers have investigated the spermatogenic cycle, trying to quantify 
the length of the cycle and determine the number of cycle stages in the different species. 
There are different methods used to determine the cycle length. The first one was to use X-
ray irradiated testis to investigate the rate of germ cell disappearance due to the destruction of 
the SSCs (263-265). The second method was to label the developing germ cells with 
radioactive elements and trace these cells through their development (266-268). For instance, 
the length of the cycle in the rat was estimated to be 12.9 days (269), while the length of the 
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cycle in humans was estimated to be 16 days (270). A lot of effort has been invested in an 
attempt to determine the stages of the cycle in the different species. In the rat, Leblond and 
Clermont have divided the seminiferous cycle into 14 stages, despite of the presence of 
previous attempts for staging resulted in dividing the cycle into less number of stages, 
ranging from 6 to 12 stages of the cycle (262). Leblond and Clermont have used the different 
developmental stages of the spermatid to the mature spermatozoa as markers for the cycle 
stages. Hence, the first developmental stage of the spermatid represents the first stage of the 
cycle (262). In humans, similar efforts have been done for staging the cycle, which divided 
the seminiferous cycle into 6 consecutive stages (226,271). 
One characteristic difference between humans and rodents regarding the spermatogenic cycle 
is that one cross section of the adult testis can show histologically more than one stage of the 
cycle in humans, while it shows only one stage of the cycle in rodents. The reason behind this 
fact is that the number of mitotic divisions of the germ cells prior to meiosis is very small in 
humans compared to the rodents. This leads to the presence of a small number of germ cells 
in each developmental stage in humans compared to rodents, which might have thousands of 
cells in the same stage. This in turn results in a smaller area of the seminiferous tubule 
occupied by these cells in humans compared to rodents. Hence, one cross section of the 
seminiferous tubule in an adult human testis can show more than one cycle stage, while it is 
not the case in rodents (260). It is worth mentioning that the spermatogenic cycle is different 
from the seminiferous epithelium wave. While the spermatogenic cycle is the time taken by a 
specific stage of the cycle to re-appear at the same spot of the seminiferous tubule, the 
seminiferous epithelium wave describes more the distance between two successive spots of 
the seminiferous tubule with the same stage of the cycle (260). 
1.3.3 Hormonal regulation of spermatogenesis 
In mammals, the beginning of spermatogenesis coincides with the onset of puberty. The onset 
of puberty in humans comes after a lag period in the infancy period, where the testis seems 
quiescent. On the contrary, the onset of puberty in the rodents is overlapping with the infancy 
period, which suggests that the quiescent period is missing in rodents (158). Interestingly, the 
initiation and maintenance of spermatogenesis is under the control of the hypothalamus-
pituitary-gonadal endocrine axis (234,272). Around puberty, kisspeptin, which is released in 
the brain, stimulates the secretion of the gonadotropin releasing hormone (GnRH) from the 
hypothalamus (273). The GnRH stimulates in turn the pituitary gland to secrete the 
gonadotropins; FSH and the luteinizing hormone (LH). 
Actually, FSH exerts its effect on the Sertoli cells through the FSH receptor (FSHR). This 
receptor starts to be expressed in the Sertoli cells at 14.5 dpc in the rat testis, and continues to 
be expressed throughout the whole adult life. However, it becomes fully active only at 16.5 
dpc in the rat (274). Stimulation of the FSHR in the Sertoli cell results in two different 
effects, depending on the level of maturation of the Sertoli cell. In the immature Sertoli cells, 
stimulation of the FSHR results in an increased proliferation rate (275,276). Meanwhile, in 
the fully mature Sertoli cells, stimulation of the FSHR results in an increased metabolic and 
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secretory activity of the Sertoli cell (277). However, the expression of the FSHR is not 
changed in both cases (278). The stimulation of the FSHR leads to a cascade of events 
resulting in the increase of cAMP. However, this effect is also dependent on the maturity of 
the Sertoli cells; the immature Sertoli cells have a much profound and enhanced effect 
compared to the mature ones (279). Notably, FSH secretion from the pituitary gland is under 
the control of the negative feedback from the testis. Sertoli cells produce inhibin in response 
to the FSH stimulation, which in turns reduce the pituitary secretion of FSH (280). Although 
the role of FSH in the Sertoli cell proliferation and maturation is well-established, the role in 
spermatogenesis is still controversial (281). Interestingly, some reports have shown that FSH 
is not needed for restoration or maintenance of spermatogenesis in adult rats (282-284). 
However, other reports showed the importance of FSH in spermatogenesis (285). The 
suggested effect of FSH on its receptor in the mature Sertoli cell, although the cAMP 
production is not enhanced as in the immature cell, can be attributed to another signal 
transduction pathway like the Ca
++
 signaling (281). 
On the other hand, LH exerts its effect on the Leydig cells through the Luteinizing 
Hormone/Choriogonadotropin Receptor (LHCGR). The LHCGR receptor is expressed in 
both the fetal and adult Leydig cells. In the fetal cells, the receptor is expressed from 16 dpc 
in rodents. The LH main two actions are to stimulate the differentiation of the progenitor 
Leydig cells to the adult Leydig cells and to stimulate the Leydig cells to produce testosterone 
and dihydrotestosterone. However, it was reported that LHCGR receptor is not needed for 
testosterone production by the fetal Leydig cells (286). The effect of LH on Leydig cells is 
mediated through the induction of the Steroidogenic Acute Regulatory Protein (STAR). This 
protein is responsible for transferring cholesterol into the mitochondria, which potentiate the 
biosynthesis of testosterone (287). The testosterone produced by the Leydig cells has a 
negative feedback on the pituitary gland LH secretion. The feedback is achieved through the 
metabolites of testosterone; estradiol and dihydrotestosterone (288). The testosterone 
produced by the Leydig cells act through the androgen receptors (AR), which are found in 
Sertoli cells, Leydig cells and PMCs. Interestingly, there are neither FSHRs nor ARs in the 
germ cells at any developmental stage. Therefore, the effect of FSH and testosterone on 
spermatogenesis is mediated through the Sertoli cells (289). However, the existence of 
estrogen receptors in germ cells has been reported, which suggests a possible effect of 
estradiol on spermatogenesis (mediated by the positive effect on germ cell survival) (290-
292). 
Other hormones with a suspected role in spermatogenesis include osteocalcin, thyroxin, 
glucocorticoids, and prolactin. Osteocalcin was reported to enhance the testosterone 
production by Leydig cells (293). Meanwhile, the thyroid hormone is responsible for the 
maturation and cessation of proliferation of the Sertoli cells (294). Glucocorticoids inhibit the 
testosterone production in the Leydig cells by suppressing the steroidogenic enzymes (295). 
Finally, prolactin has been shown to support the LH mediated testosterone production in the 
Leydig cells (296). 
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1.3.4 Somatic cell environment 
The presence of a healthy somatic cell environment in the mammalian testis surrounding the 
germ cells is extremely important in spermatogenesis. Germ cells are surrounded by 4 types 
of cells; Sertoli cells, Leydig cells, PMCs, and immune cells, with each type of cells having a 
specific role in spermatogenesis. 
The Leydig cells produce testosterone in response to the LH signaling. Then, the produced 
testosterone, acts on three types of cells which have the ARs in the testis. These types of cells 
include Sertoli cells, PMCs and Leydig cells. The AR signaling in Leydig cells is a sort of 
feedback mechanism, which enhances the Leydig cell proliferation and differentiation 
(297,298). Leydig cells produce also colony stimulating factor 1 (CSF1), which influence the 
proliferation of SSCs through the CSF receptors on the surface of the SSCs (299,300). 
In the PMCs, the AR signaling is important for the formation of the basement membrane and 
for the cross talk with Sertoli cells. The PMC specific AR knockout mice showed impaired 
spermatogenesis and Sertoli cell function, showing the importance of the AR signaling in the 
PMCs (301). Another signaling pathway in the PMCs is through the platelet derived growth 
factor (PDGF) signaling. Notably, Sertoli cells produce PDGF, which acts on the PMCs 
through the PDGF receptors (302). The direct effect of PMCs on germ cells can be attributed 
to the Glial Cell Derived Neurotrophic Factor (GDNF) and LIF secreted by the PMCs, which 
can act on germ cells through the GFRα receptors and LIF receptors found on SSCs (303). 
However, GDNF secretion is to some extent under the control of the PDGF signaling coming 
from Sertoli cells (302). 
Since mature Sertoli cells have FSHRs and ARs, they receive two important signals by two 
hormones; FSH, and testosterone. The FSH signaling stimulates the proliferation of SSCs, 
mediated by GDNF, FGF2, and c-KIT ligand or stem cell factor (SCF) (304-306). 
Meanwhile, the AR signaling in Sertoli cells is important for entering the meiotic phase of 
spermatogenesis, through the production of RA, which is important for the germ cells to enter 
meiosis (306). Both FSH signaling and testosterone signaling in the Sertoli cell are crucial in 
the spermiogenesis stage and to complete the spermatogenesis process (233,289). In addition 
to the classical genomic pathway through the AR, testosterone exerts its effect on Sertoli cells 
through a non-genomic pathway, where the testosterone induces Ca
++
 influx and stimulates 
Src tyrosine kinase. This non-classical pathway is important in the Sertoli cell-germ cell 
attachment and the release of the mature spermatozoa into the lumen (307). Moreover, Sertoli 
cells produce also transferrin, activing A and BMP4. The GDNF produced by Sertoli cells 
acts on the SSCs through the GFRα and c-RET receptors. The main role of GDNF is to 
regulate the self-renewal of the SSCs through the AKT signaling pathway and the Src family 
kinase signaling pathway (308-311). In addition, Sertoli cells produce FGF2, which regulates 
the self-renewal of the SSCs as well, by enhancing the self-renewal genes (312). Another 
factor produced by the Sertoli cells is the SCF, which stimulate the differentiation of the 
spermatogonia through the c-KIT signaling. It is worth mentioning that in the undifferentiated 
spermatogonia the c-KIT expression is inhibited by the ZBTB16 expression (313). 
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Meanwhile, the RA produced by Sertoli cells is important for the germ cells to enter meiosis 
through the STRA8 signaling pathway (314,315). Transferrin produced by Sertoli cells, on 
the other hand is responsible for shuttling iron to the developing germ cells (316). Finally, 
Sertoli cells produce activing A and BMP4, which induce the differentiation of SSCs through 
the SMAD signaling pathway (317,318). 
The immune cells surrounding the germ cells include macrophages, leukocytes, and mast 
cells. These cells produce a group of factors called cytokines; such as interleukin 1 α (IL1α), 
IL1β, IL6, interferon γ, tumor necrosis factor α (TNFα) and TGFβ. These factors have a 
direct effect on the proliferation and differentiation of the germ cells and somatic cells in the 
testis (319,320). In addition, TNFα and TGFβ initiate the disassembly of the BTB during the 
movement of germ cells across the BTB. This disassembly is important to allow the germ 
cells to pass the BTB (321). Afterwards, the BTB re-assemble once more under testosterone 
effect, dividing the intra-tubular compartment into two regions; one for the haploid post-
meiotic cells with no access to blood components, and one for the diploid pre-meiotic cells 
exposed to the blood components (322,323). Macrophages produce also CSF1 and RA, 
which are important for SSCs self-renewal and entry of meiosis as discussed earlier. The 
significance of macrophages in spermatogenesis was shown by their ablation in the testis, 
which caused a disturbance in spermatogenesis (324). 
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1.4 FERTILITY PRESERVATION IN MALES 
Fertility preservation is the measures and procedures taken to save, retain or restore the 
fertility for males who are at high risk to develop infertility. In males, this infertility is 
defined as the inability of a person to reproduce with a natural sexual intercourse due to 
reduced qualitative or quantitative parameters of the semen. Therefore, the indications for 
fertility preservation (in particular, the cancer treatments) and the current and future options 
for fertility preservation in males (in particular, in vitro spermatogenesis) will be discussed. 
1.4.1 Indications for fertility preservation in males 
The indications for fertility preservation in males include the syndromes or diseases that can 
eventually lead to infertility, or the exposure to specific treatments that are used to treat some 
syndromes or diseases. 
1.4.1.1 Syndromes and conditions causing infertility 
These conditions include Klinefelter syndrome and cryptorchidism (325). Klinefelter 
syndrome (KS) is a chromosomal disorder with a prevalence of 0.2% in males, which results 
usually from the existence of 3 sex chromosomes; a pair of X chromosomes and one Y 
chromosome (326). Individuals with KS show normal onset of puberty and a brief testicular 
growth. However, this growth declines shortly after the onset of puberty, with elevated 
gonadotropins and reduced testosterone levels in serum (hypergonadotropic hypogonadism). 
In addition, the germ cells at the spermatogonial stage proceed to apoptosis instead of 
entering meiosis, leading to meiotic arrest and loss of germ cells (327-329). The fertility 
preservation recommendation for such condition is to cryopreserve the retrieved sperm or 
semen for adolescents or to cryopreserve the testicular tissue for pre-pubertal boys (330-333). 
However, it is rare to find pre-pubertal boys with KS, as it is usually diagnosed after the onset 
of puberty. Notably, SSC transplantation is not recommended for such individuals, as the 
deterioration of the seminiferous tubules occurs later on in life, which will make the 
restoration of a normal spermatogenesis impossible (334,335). 
On the other hand, cryptorchidism is a congenital condition where one testis or both testes 
remain retracted in the abdomen without descending into the scrotum at birth or shortly after 
birth within 3 months. The hyper-thermal conditions the germ cells face at this early 
developmental stage causes a progressive loss of germ cells. Its prevalence is approximately 
1-3% of the newborn males, with a serious prognosis of prospected infertility in the 
adulthood and high risk to develop germ cell tumors (336,337). Surgical intervention is 
indicated in such condition as early as at the age of 6 months, to minimize the undesirable 
consequences (338). As the bilateral orchidopexy has a worse prognosis than the unilateral 
one, it is a technical routine to take a testicular tissue biopsy during the surgical operation, to 
investigate whether the germ cells are still present or not (339). In that context, 
cryopreserving the testicular tissue for further fertility preservation options if needed was 
suggested (325,340). 
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1.4.1.2 Gonadotoxic treatments 
Some treatments are highly effective against the diseases and conditions they are intended to 
cure. However, these treatments have a major side effect; which is the gonadotoxic effect. 
The gonadotoxic effect is defined as any deleterious effect to the gonads; causing subfertility 
or infertility. The conditions or diseases treated by such gonadotoxic treatments include 
systemic lupus erythematosus, some renal diseases, sickle cell anemia, Fanconi anemia, 
multiple sclerosis, and, most important, cancer (341,342). 
Systemic lupus erythematosus, multiple sclerosis and some renal diseases necessitate 
cyclophosphamide as a treatment, which is known for its gonadotoxicity (343-347). In 
addition, sickle cell anemia and Fanconi anemia are two conditions that are treated mainly by 
hemopoietic stem cell transplantation (HSCT) (348,349). This HSCT needs some sort of 
preparation before the transplantation called conditioning, which implies total body 
irradiation (TBI) and the usage of cyclophosphamide or busulfan; both of which are known to 
cause gonadotoxicity (350,351). 
1.4.2 Effect of cancer therapy on testis 
Cancer therapy is by far the major indication for fertility preservation. Cancer is defined as a 
group of diseases characterized by abnormal cell growth, which has the ability to spread or 
invade other tissues. Hence, treating cancer depends in the first place on inhibiting cell 
growth and multiplication. To achieve such goal, there are two main components in most of 
the cancer treatment protocols; chemotherapy and radiotherapy. Chemotherapy is a term 
describes a group of medications that possess a toxic effect on the proliferating cells. These 
medications are called collectively cytotoxic agents, as they inhibit cell proliferation by 
different mechanisms, classifying them to different classes. These classes include mainly two 
classes; the alkylating agents (e.g. cyclophosphamide, busulfan, and ifosfamide), which cause 
damage to the DNA and induce apoptosis, and antimetabolites (e.g. methotrexate), which 
inhibit DNA and RNA synthesis. Meanwhile, radiotherapy is based on the deleterious effect 
of the ionizing radiation on DNA, leading to cell death by apoptosis (325,352).  
The effect of the treatment on testis, and therefore fertility, is extremely harmful. In general, 
A dark spermatogonia in humans are the reserve SSCs, which do not proliferate in the normal 
healthy testis, while the A pale spermatogonia proliferate regularly to produce differentiated B 
spermatogonia. However, the A dark spermatogonia do proliferate if the A pale spermatogonia 
are depleted. Thus, A dark spermatogonia are more resistant to damage by gonadotoxic 
treatments than other types of spermatogonia (353,354). In addition, the repeated exposure or 
exposure to very high doses of gonadotoxic treatments can deplete the pool of the A dark 
spermatogonia and cause damage to the somatic cell environment in the testis (354,355). The 
effect of chemotherapy or radiation depends on the age of the patient and the type, dose and 
duration of treatment (356). In childhood, all of the testicular cells have a high turnover rate, 
which makes them more sensitive than the adult testicular cells (355,357). Moreover, 
childhood malignancies per se may have a deleterious effect on the testis (358-361) 
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1.4.2.1 Effect of chemotherapy on testis 
Not all chemotherapeutic agent cause the patients to develop the same risk for infertility, 
some agents imply more risk than the others. Hence, there are some agents with high risk (the 
alkylating agents) and some agents with low risk (the antimetabolite agents) (355). This is 
because alkylating agents deplete the spermatogonial pool by damaging directly the DNA, 
which induces apoptosis (362). For instance, cyclophosphamide with a dose of 9 g/m
2
 for 
pre-pubertal patients and a dose of 10 g/m
2
 for post-pubertal patient cause prolonged 
azoospermia (363-365). However, a recovery of spermatogenesis occurred in many cases 
with these doses, suggesting higher doses of cyclophosphamide are required to develop a 
permanent azoospermia (366). Busulfan on the other hand requires a dose of 600 mg/kg to 
exhibit the same effect (367). Thus, a low dose of alkylating agents can cause depletion of the 
A pale spermatogonia with a recovery after a while, and a reversible azoospermia in adults. 
Meanwhile, a high dose of alkylating agents can cause permanent infertility in all ages (355). 
It is also worth mentioning that repeated low doses of cyclophosphamide implies more risk 
for infertility than single high dose, as the repeated doses can deplete the reserve A dark 
spermatogonia (368). 
The effect of chemotherapy on Leydig cells seems attenuated if compared to the effect on 
germ cells. However, the exposure to alkylating agents can cause Leydig cell damage, 
characterized by increased LH levels as a compensatory mechanism, which results usually in 
normal testosterone levels (354,369). Therefore, neither pre-pubertal nor post pubertal 
patients exhibit any signs of Leydig cell damage (e.g. delayed secondary sexual development 
for pre-pubertal and low testosterone levels for post-pubertal) after the exposure to low dose 
of alkylating agents (370). However, higher doses of alkylating agents can cause severe 
damage to the Leydig cell, leading to apparent dysfunction (371). 
1.4.2.2 Effect of radiotherapy on testis 
Effect of radiotherapy on the testicular functions depends on the field, dose and fractionation 
of radiation (372,373). A low total dose of 0.1 Gray (Gy) can cause disturbance of 
spermatogenesis for a short time, while higher doses of 2-3 Gy can cause a prolonged 
azoospermia. A high total dose of radiation (more than 6 Gy), on the other hand, can cause 
permanent azoospermia, leading to infertility (374-376). Fractionation of the radiation might 
lead to more severe toxicity to the testis. Thus, a total fractionated dose of 1.2 Gy can cause 
permanent infertility (377,378). On the other hand, a recent study presents different data, 
where the fractionated dose had a more tolerable effect than the single dose of irradiation 
(379). The field of radiation is a major factor upon which the gonadotoxic effect depends. In 
case of TBI, needed before HSCT, a total dose of 12 Gy can cause permanent infertility 
(380,381). Meanwhile cranial irradiation with a dose of 30-50 Gy in brain tumors can lead to 
secondary infertility, due to disturbance in the hypothalamic-pituitary-gonadal axis (382-
385). Testicular irradiation (in pre-pubertal patients for testicular leukemia or in post-pubertal 
patients for testicular cancer) is usually at a dose of 20-24 Gy, which is sufficient to cause 
permanent infertility, due to germ cell depletion (374,386). 
  25 
Leydig cells, albeit less sensitive than germ cells to radiotherapy, can be affected by the 
testicular irradiation at a dose of 24 Gy, leading to impaired testosterone production and 
delayed puberty, which necessitates hormonal therapy (373,387). However, adults who 
receive a dose of 20 Gy of testicular irradiation or less could exhibit normal testosterone 
production (372,381,388). Nevertheless, using new radiotherapy techniques can cause less 
damage to the testis, such as the high-dose-rate brachytherapy (HDRBT) given neoadjuvantly 
for patients with rectal cancer (389). 
1.4.3 Fertility preservation options in males 
In the few past decades, cancer treatment protocols have improved a lot, leading to a dramatic 
increase in the survival rates, reaching about 80% in childhood cancers (390,391). 
Meanwhile, leukemia represents 30% of all pediatric malignancies, with acute lymphoblastic 
leukemia (ALL) constituting two thirds of the leukemia cases (392). However, the 
advancement in cancer treatments did not guarantee better adverse effects. As the increased 
risk for infertility is one of the main adverse effects, it was not an exception (393-395). Thus, 
about 46% of the childhood cancer survivors and more than 40% of the ALL survivors have 
reduced fertility (396-399). However, these figures tend to improve with time after treatment 
(370). In addition, using antimetabolites instead of the high dose alkylating agents improved a 
lot the fertility outcome for the survivors (368,400). On the other hand, Hodgkin’s lymphoma 
(HL) patients treated with alkylating agents had much worse fertility parameters compared to 
the HL patients who did not receive alkylating agents in their treatment protocol, or even 
compared to the ALL patients (401-406). Meanwhile, non-Hodgkin’s lymphoma (NHL) 
treatment protocol leaves the patients with a risk of infertility similar to the ALL patients. In 
case of relapse (about 30% of the cases), these patients require an HSCT operation, which 
necessitates conditioning with TBI and high dose of cyclophosphamide, rendering the 
patients with high risk to develop infertility (379-381,407). 
As the survival rate after childhood cancer increased, the demand on fertility preservation 
increased as well. Hence, it was important to investigate the fertility preservation options for 
such patients. Herein, the current options for fertility preservation in males and the 
experimental techniques that could be used in the near future will be discussed. 
1.4.3.1 Current options for fertility preservation in males 
The options depend to large extent on the pubertal stage of the patient. If the male patient is 
post-pubertal or pubertal, the safest and easiest option is to cryopreserve a semen sample 
form the patient, obtained mainly by masturbation (408). However, electro-ejaculation, 
vibratory stimulation and testicular sperm extraction (TESE) can be used as well. Later on, 
these samples can be thawed and the sperm used by assisted reproductive techniques (ART) 
to achieve pregnancy (325,367,409). Thus, semen cryopreservation should be offered to all 
patients with fertility preservation indication, regardless to the risk to develop infertility, once 
they can deliver semen sample. However, if the male patient is pre-pubertal or cannot deliver 
semen sample, there is no current proved clinical method for fertility preservation (Figure 3). 
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1.4.3.2 Experimental techniques for fertility preservation in males 
As semen cryopreservation is not always feasible, there are some techniques under 
investigations as options for fertility preservation. These techniques are intended for pre-
pubertal patients as well as azoospermic pubertal patients due to pre-treatment or the 
malignancy itself (403,410). These techniques include gonadal protection, testicular 
cryopreservation, autologous transplantation (SSCs or tissue), xeno-grafting of testicular 
tissue, and in vitro germ cell maturation (325,355,367). 
 
 
 
Figure 3. Fertility preservation options in males. The risk for infertility is assessed. In case of low 
risk, while a semen sample can be obtained, sperm cryopreservation is performed. The cryopreserved 
sperm can be used later exploiting assisted reproductive techniques (ART) to produce pregnancy. In 
case of high risk (hemopoietic stem cell transplantation HSCT with total body irradiation TBI), while 
a semen sample can be obtained, sperm cryopreservation is performed as well, followed by ART 
when required. In case of high risk, while a semen sample is not feasible, a biopsy of testicular tissue 
is obtained instead. If it is possible to get sperm through testicular sperm extraction (TESE), 
cryopreservation for the sperm is performed. If it is not possible to extract sperm, the testicular tissue 
is cryopreserved for later ex vivo germ cell differentiation if possible. The green boxes indicate a 
current fertility preservation option, while the red boxes indicate an experimental technique, not a 
guideline yet. 
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Gonadal protection is a technique aiming at suppressing the hypothalamic-pituitary-gonadal 
axis by GnRH agonist or antagonist, leading to gonadal quiescence. This quiescence should 
turn the germ cells less sensitive to chemotherapy and radiation (411). Gonadal protection has 
shown some promising results in rats more than in mice (412-417). However, no such 
encouraging results could be obtained in humans or non-human primates (NHP) (418-420). 
Testicular cryopreservation is a technique designed for storing the testicular tissue for long 
term at a very low temperature (liquid nitrogen temperature, -196°C). Hence, when the male 
patient is pre-pubertal or cannot deliver semen samples, the risk to develop infertility due to 
the treatment is evaluated. If the risk is high, the patient should undergo an invasive surgical 
operation to obtain a testicular biopsy and cryopreserve it. Testicular biopsy should be taken 
ideally before introducing any treatment to the patient. Testicular tissue cryopreservation is 
considered as the cornerstone for the experimental techniques of fertility preservation, as the 
germ cells can be stored by this preservation and they could be used later in the different 
techniques; autologous transplantation, xeno-grafting, and in vitro germ cell maturation. So 
far, there are two methods for cryopreservation; slow freezing and vitrification. In the slow 
freezing method, the tissue is stored with a cryoprotective agent, which can be diffusible (e.g. 
ethylene glycol and dimethyl sluphoxide or DMSO) or non-diffusible (e.g. polymers). The 
role of the cryoprotective agent is to inhibit the cytotoxicity due to the ice crystal formation. 
On the other hand, in vitrification, the tissue is frozen in an extremely short time, in order to 
inhibit the formation of ice crystals and to avoid the relevant cytotoxicity. Recently, there is 
an advancement in the testicular tissue cryopreservation protocols, which will enable 
researchers to focus on the way the germ cell can mature ex vivo (395,421-426). Noteworthy, 
cryopreservation of single cell suspension instead of the tissue could be easier. However, this 
suspension necessitates enzymatic and mechanical digestion, which will compromise the cell 
survival (427). 
Autologous transplantation is a technique aiming at transplanting the testicular tissue or 
SSCs, with or without cryopreservation, back into the donor’s testis. Transplantation of SSCs 
in mice has been reported earlier, where spermatogenesis could be re-established in germ cell 
ablated seminiferous tubules (428,429). After mating, these mice could reproduce and the 
offspring was fertile as well (430). Notably, neither the donor’s age nor cryopreservation of 
the SSCs did affect the outcomes (431-433). In addition, it has been reported that 
transplantation of SSC of rhesus monkey could re-establish spermatogenesis in the testis of 
busulfan-treated and X-ray treated rhesus monkey recipients (434,435). Using the same 
technique, SSCs could be transplanted in human cadaver testes as well (436). Since the 
number of SSCs in the testis is limited, a step of propagating the SSCs in vitro prior to the 
transplantation might be required (437). This step has been reported to be feasible recently 
(438,439). On  the other hand, the outcome of testicular tissue transplantation depends on the 
age of the donor; where the testicular tissue from immature animals had better survival and 
ability to re-establish spermatogenesis than the testicular tissue from adult ones (440-442). 
Using this grafting technique, spermatogenesis could be established after grafting neonatal 
testicular tissue from different species into nude mice, producing an offspring from the 
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obtained mature spermatozoa (443-446). Autologous grafting for NHP testicular tissue in 
orthotopic and ectopic positions has been reported earlier, with a success in producing mature 
spermatozoa using fresh and cryopreserved tissue (447-449). Noteworthy, testicular tissue 
grafting produced more efficient spermatogenesis in mice than transplantation of SSCs (450). 
Although autologous transplantation, for tissue or SSCs, seems promising technique, it is still 
a research tool more than a clinical option. The reason behind this is that in case of many 
pediatric malignancies (e.g. ALL), testicular tissue might be a infiltrated with cancerous cells 
(451). Hence, grafting testicular tissue may imply the risk for recurrence of cancer, as a few 
cancer cells are required to re-establish the disease (452). In that context, transplantation of 
SSCs might look better, as the testicular cells are dissociated and the isolated cells should be 
only the SSCs. However, finding a de-contaminating protocol for the SSCs from the 
leukemic cells seems challenging, rendering SSC transplantation as a research tool only (453-
456). This is mainly due to the difficulty to find a specific surface marker for SSCs (457). 
Nonetheless, a recent study showed that a full de-contamination protocol could be achievable, 
which might be promising (456). 
Xeno-grafting of testicular tissue describes transplanting testicular tissue from one species 
(e.g. human) into another species (e.g. nude mice). So far, spermatogenesis could be 
established by grafting monkey testicular tissue (NHP) in nude mice (458). However, 
complete spermatogenesis from human xeno-grafting in nude mice has not been reported yet, 
although meiotic activity could be observed (459-462). Unequivocally, considering xeno-
grafting as a clinical tool is quite far, due to the risk of zoonosis. However, it can be used as a 
tool to detect any contamination with leukemic cells in the testicular graft, as it will reproduce 
the cancer in the recipient animal (463). 
1.4.4 In vitro germ cell maturation 
As it was discussed previously, the experimental techniques for fertility preservation are a bit 
far from the clinic in the time being. Hence, the only technique that avoids the setbacks for 
the other techniques is the in vitro germ cell maturation or in vitro spermatogenesis (IVS) 
(464). It aims at culturing in vitro the testicular tissue, taken from the pre-pubertal patients at 
high risk to develop infertility before starting treatment, in order to get mature germ cells. 
These mature germ cells can be, in principle, used later with ART to achieve pregnancy when 
desired. Hence, this method avoids the risk for cancer recurrence (as in autologous 
transplantation) and the risk for zoonosis (as in the xeno-grafting) (325,367,465). 
Studies on IVS started a century ago (466). Meanwhile a lot of efforts in IVS were performed 
in the 60’s by Steinberger (467,468). However, these studies showed the progression of 
spermatogenesis till meiosis, followed by a meiotic arrest. Since then, studies on IVS 
revealed that IVS depends on a lot of factors; such as the pH, the temperature (467,469,470), 
the cell-cell contact (471,472), the oxygen level (230), the culture method, the composition of 
the culture medium, and presence or absence of serum, hormones and some growth factors 
(473,474). There are 3 major methods for IVS; conventional two-dimensional cell culture, 3D 
culture, and organ culture. 
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1.4.4.1 Conventional two-dimensional (2D) culture system 
In the conventional 2D cell culture, germ cells are cultured in liquid culture medium, with or 
without other types of cells. Interestingly, studies on IVS using 2D culture showed the 
progress of spermatogenesis from meiotic stage to the post meiotic stage (475-477). In these 
studies, spermatocytes and round spermatids were obtained from testicular biopsies of non-
obstructive azoospermia patients and co-cultured with Vero cells or Sertoli cells. The co-
cultured germ cells could develop to elongated spermatids and spermatozoa. Moreover, these 
elongated spermatids had normal blastocyst formation rates when used to fertilize oocytes in 
vitro. The studies showed also that FSH and testosterone, when added simultaneously to the 
culture, showed improved differentiation and meiosis index. In addition, studies on IVS using 
germ cells at earlier stages of development have been reported (478,479). In these studies, 
SSCs were isolated from obstructive azoospermia and non-obstructive azoospermia patients, 
as CD49f+ cells, or from cryptorchid patients. These SSCs were co-cultured with Sertoli cells 
and developed in vitro to post-meiotic round spermatids. The round spermatids had normal 
fertilization potential when used in fertilizing oocytes. However, no full spermatogenesis has 
been reported using this 2D culture system, probably due to the loss of the spatial 
arrangement of the testicular cells in vitro by this method, which has been shown to be 
important to achieve germ cell maturation (480).  
1.4.4.2 Three-dimensional (3D) culture system 
In an attempt to keep the spatial arrangement of the germ cells with the other testicular cell 
types in vitro, the use of agarose or methylcellulose to form a 3D semi-solid culture system 
was investigated (481). The use of extracellular matrix (ECM) in cell culture started earlier to 
establish clonogenic assays for hemopoietic stem cells (HSCs) (482). In their study, 
Stukenborg and colleagues obtained a single cell suspension from testes of 10 dpp mice. 
Using magnetic-activated cell sorting (MACS), the cells were separated into two fractions, 
depending on the GFRα expression; SSCs enriched and SSCs depleted. The two fractions 
were inoculated into two layers of a 3D matrix, formed of agarose and culture medium. This 
study showed the importance of functional somatic cells to IVS, since the fraction with SSCs 
co-cultured with somatic cells had Crem and Boule positive cells. In another study, the same 
group showed that the murine SSCs could develop to elongated spermatids, expressing 
protamine on protein level. They have also shown gonadotropins were essential for germ cell 
differentiation in vitro. In additions, the nature of the matrix, being agarose or methyl 
cellulose, did not have an effect on the culture system. However, the efficiency of this 3D 
culture system to produce mature germ cells was low (480). Other groups have earlier 
reported using the same concept of 3D culture system to differentiate germ cells from other 
species (e.g. rat and human) in vitro. In one study, Lee and colleagues isolated single cell 
suspension from testes of 18 dpp rats. This suspension was inoculated into monolayer culture, 
collagen matrix culture, or collagen + Matrigel. The group has shown that the 3D culture 
system support the differentiation of the germ cells to the post-meiotic stage. The same group 
has cultured spermatocytes from testicular biopsies of non-obstructive azoospermia patients 
in a 3D collagen culture system. The results showed that these spermatocytes could 
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differentiate to haploid cells in vitro, using the 3D culture system (483,484). However, the 
starting material that they used did not contain only SSCs, but more developmentally 
advanced germ cells were included in the culture. Thus, a full spermatogenesis in vitro could 
not be claimed. 
1.4.4.3 Organ culture system 
Usage of the organ culture for IVS has started decades earlier (468). In their studies, 
Steinberger and colleagues utilized the organ culture method, which was developed 
previously by Trowell (485). Interestingly, the tissue was cultured at the interface between 
the liquid phase and the gaseous phase, permitting the tissue to have access to the nutrients in 
the liquid phase and oxygen in the gaseous phase. The privilege in using the organ culture 
technique is that the spatial arrangement for the testicular cells is preserved in vitro, keeping 
testicular architecture with the same type of surrounding cells as in vivo. However, for 
decades, it was not possible to show full spermatogenesis in vitro in any species. Some 
reports showed human germ cell differentiation in vitro using the organ culture method, but 
still it was not full spermatogenesis (486,487). In his study, Tesarik and colleagues isolated 
seminiferous tubules from testicular biopsies of obstructive azoospermia patient. The isolated 
tubules were cultured in vitro in an organ culture setup, resulting in post-meiotic sperm cell 
differentiation. Moreover, the in vitro developed spermatids could be used in fertilizing 
oocytes, which indicates to the functionality of these spermatids. 
In 2010, Gohbara and his group could show full spermatogenesis in vitro in mice, using 
organ culture technique (488). The group has cultured testicular tissue form transgenic mice 
at 4.5-14.5 dpp in an organ culture setup. The transgenic mice were expressing green 
fluorescent protein (GFP) exclusively in the germ cells at the mid-meiotic stage (Acr-GFP) 
and the end-meiotic stage (Gsg2-GFP). The group has cultured the testicular tissues on 
agarose stands, to be at the interface between the gaseous phase and the liquid medium phase. 
The cultured tissues resulted in the presence of post-meiotic round spermatids. One year later, 
the same group has proved the functionality of the produced mature germ cells, by producing 
healthy offspring that was fertile as well (489). Later on, they used SSCs, adult testicular 
tissue, and cryopreserved neonatal tissue instead of the fresh neonatal testicular tissue, in 
order to prove the concept (490-493). One important modification the group has made was 
introducing Minimum Essential Medium alpha (MEMα) and KSR to the culture medium 
instead of the normal fetal bovine serum (FBS). Using FBS in IVS earlier usually resulted in 
meiotic arrest. This KSR was intended to be used for stem cell propagation, keeping their 
stemness and preventing their differentiation (494). Surprisingly, using KSR in murine 
testicular tissue culture induced germ cell differentiation. Using the organ culture technique, 
other groups have reported male germ cell differentiation as well (495-497). In these studies, 
the authors have used the organ culture technique to assess the effect of retinol and the 
cryopreservation temperature on murine germ cell differentiation in vitro. However, full 
spermatogenesis in vitro has never been reported in humans. The reason behind the difficulty 
in human germ cell differentiation in vitro is still not fully understood. However, the 
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differences in the hormonal regulation of spermatogenesis between the different species, with 
some differences in the spermatogenesis process itself, might explain this difficulty. 
In an attempt to explore the ECM in the testis, it has been reported that there are more than 
100 proteins present in the ECM after decellularizing human testis, which opens the door for 
studying the role of ECM in spermatogenesis in vivo (498). More important, it could be of 
great implication to use the decellularized testicular matrix (DTM) as a scaffold to culture 
testicular cells in vitro. 
Certainly, production of the mature spermatozoa from the immature germ cells is the 
objective of IVS. However, the ultimate goal is to use the produced mature germ cells to 
produce offspring. Although it has been shown in mice that the produced offspring by IVS is 
healthy and fertile, it is still not the case in humans. First, the production of mature 
spermatozoa from immature testicular tissue has not been shown in humans yet. Second, as 
we should be more cautious when it comes to humans, even if the mature human 
spermatozoa are produced by IVS, it is not the end of the story. Still, we need to investigate 
the genetic and epigenetic stability of the produced haploid cells before using them in ART to 
produce pregnancy, since the genetic and epigenetic status of the cells can differ after culture. 
In the same context, effect of the long-term culture on SSCs genetic and epigenetic profiles 
has been evaluated (499-501). 
It is noteworthy that in vitro germ cell maturation will addressed in detail in the results and 
discussion section of the separate studies included in the thesis, as this is the main aim of the 
thesis. 
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2 AIM OF THE THESIS 
 
The overall aim of this thesis was to elucidate the mechanisms involved in the male germ cell 
development in vitro, with the ultimate goal of establishing an in vitro model for human 
spermatogenesis as a clinical tool in future. 
 
The specific aims of the four projects were: 
 
1. To investigate whether the culture conditions and gene expression profile could be 
used to predict the differentiation potential of hES cells in vitro towards male germ 
cells. 
 
2. To optimize the culture conditions for rat male germ cell differentiation in vitro using 
a three-dimensional culture system. 
 
3. To investigate the possibility of producing mature rat male germ cells in vitro from 
immature pre-pubertal testicular tissue, exploiting the optimal organ culture 
conditions  that were published for mouse previously. 
 
4. To study the effects of long term in vitro culture on testicular tissues from pre-
pubertal patients, prior to or during gonadotoxic therapy, using the previously 
published organ culture technique. 
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3 MATERIAL AND METHODS 
3.1 ETHICS 
3.1.1 Human embryonic stem cells (hES cellss) 
In paper I, the hES cell lines HS207 (XY), HS360 (XY) and HS401 (XY) were derived at 
Karolinska Institutet hospital, Huddinge, Stockholm, Sweden, under the ethical approval 
obtained from the Ethics Board of Karolinska Institutet and the Regional Ethics Board in 
Stockholm with the number Dr no 454/02. 
3.1.2 Animals 
In the paper II and III, the Sprague-Dawley rats were used under the ethical approvals 
obtained from the Ethics Board of Karolinska Institutet and the Regional Ethics Board in 
Stockholm with the numbers N489/11 and N280/14. 
3.1.3 Human subjects 
In paper IV, testicular tissues were collected from the patients under the ethical approvals 
obtained from the Ethics Board of Karolinska Institutet and the Regional Ethics Board in 
Stockholm (Dnr 2013-2129-31-3) and the National Ethics Board of Iceland, Reykjavik (VSN 
15-002). Due to the fact that the patients were minors, parents of all patients gave a written 
and informed consent and the study was performed according to the amended Declaration of 
Helsinki. 
3.2 HUMAN AND ANIMAL CELLS AND TISSUES 
3.2.1 Human embryonic stem cells (hES cells) 
The ES cell lines used in paper I, with normal XY karyotyping (as we were intending to 
differentiate the cells towards male germ cells), were derived from ICM either by 
immunosurgery (HS207), using 10mg/ml protease pronase E solution (Sigma Aldrich, St. 
Louis, USA), 20% anti-human whole serum, and 20% guinea pig complement (Sigma 
Aldrich), or mechanically (HS360 and HS401) using flexible metal needles. Subsequently, 
cells were plated on mitotically inactivated feeders (64,65,502,503). While immunosurgery 
gives cleaner separation for the ICM, the mechanical separation has the advantage of being 
xeno-free. 
3.2.2 Animals 
The animals used in paper II and III were Sprague-Dawely rats, purchased with their mothers 
from Charles River (Sulzfeld, Germany), transferred to Karolinska Institutet, handled, and 
sacrificed by decapitation at the age of 5-7 dpp under the ethical approvals obtained 
previously at Karolinska Institutet. The age of 5-7 dpp was chosen so that it represents the 
same stage of development in testis as in the pre-pubertal patients. 
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3.2.3 Human subjects 
In paper IV, twelve pre-pubertal patients with different diagnoses (acute myeloid leukemia 
(AML), juvenile myelomonocytic leukemia (JMML), Wilms’ tumor, high risk 
hepatoblastoma, myelodysplatic syndromes (MDS), sickle cell anemia, Fanconi anemia, and 
thalassemia major), from nine months of age and up to 11.5 years of age, were recruited in 
the study. The exclusion criteria were mainly testis volume more than 10ml and increased 
risk of bleeding or other complications. 
3.3 CELL AND TISSUE CULTURE 
3.3.1 Stem cell culture and differentiation 
In paper I, the hES cell lines were cultured on mitotically inactivated human foreskin 
fibroblasts (hFFs; CRL-2429; ATCC, VA, USA) in Knockout Dulbecco´s Modified Eagle´s 
medium (KO-DMEM, 10829018, Gibco, Thermo Fisher Scientific, Waltham, Massachusetts, 
USA) supplemented with 20% KSR (10828028, Gibco), 0.5% penicillin-streptomycin 
(Pen/Strep, 15140122, Gibco), 2 mM L-Glutamax (35050038, Gibco), 1% non-essential 
amino acids (NEAA, 11140035, Gibco), 0.5 mM 2-mercaptoethanol (31350010 Gibco) and 8 
ng/ml rFGF2 (234-FSE/CF, R&D Systems, MN, USA) as described previously (Figure 4) 
(93,109). The medium was changed 6 times per week and the cells were passaged 
mechanically every 4-6 days using a surgical scalpel. 
To obtain the spheres, the hES cell colonies were scraped off the feeder layer with a surgical 
scalpel and transferred to 24-well ultra-low-attachment-surface plates (3473, Corning Inc., 
NY, USA) in Neurobasal medium (21103049, Gibco) supplemented with 14% KSR, 2 mM 
Glutamax, 0.5% Pen/Strep, 1% NEAA, 20 ng/ml rFGF2, 25 ng/ml rActivin A (120-14E, 
Peprotech, NJ, USA), 1.0 μg/ml human fibronectin (354008, BD Biosciences, NJ, USA), 0.5 
μg human placental laminin/ml (L6274, Sigma Aldrich), 0.001% porcine gelatin (G2625, 
Sigma Aldrich), 10 ng/ml each of recombinant brain-derived neurotrophic factor (rBDNF, 
450–02, Peprotech), recombinant neurotrophin-3 (rNT3, 450–03, Peprotech) and 
recombinant neurotrophin-4 (rNT4, 450–04, Peprotech), and 1 × Nutridoma (11011375001, 
Roche, Basel, Switzerland) as described earlier (Figure 4) (72). The medium was changed 
every other day and the spheres were passaged mechanically into 4-6 pieces by a surgical 
scalpel at intervals of 8–10 days. 
For differentiation of the cells, they were differentiated on a feeder layer without rFGF2, in 
the presence and absence of 10 ng/ml BMP7 (354-BP-010, R&D Systems). The cells were 
not passaged during differentiation and the medium was changed every other day. For 
differentiation of spheres, they were differentiated for 2 weeks either in normal non-
stimulated conditions in 50% KO-DMEM (10829018, Gibco) and 50% F12 (21127, Gibco) 
or with stimulation by adding 10 ng/ml BMP7. The spheres were not passaged during 
differentiation and the medium was changed every other day. Afterwards, cells were 
stimulated by 5 IU/L (international units per liter) each of human chorionic gonadotropin 
(hCG, Pregnyl 5000IE, Merck Sharpe & Dohme, NJ, USA) and recombinant FSH (rFSH, 
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Gonal F 75IE, Merck KGaA, Darmstadt, Germany) for 2 days. hCG has the same action of 
LH on the same receptor, but it is used widely instead of LH in research, as it is easier and 
cheaper to get.  
 
 
Figure 4. Human embryonic stem (ES) cell and testicular cell and tissue culture. In paper I, three hES 
cell lines (HS207, HS360, and HS401) where cultured either on feeder cells (human foreskin 
fibroblasts; hFFs) or in suspension culture as spheres. The main supplements were knockout serum 
replacement (KSR), basic fibroblast growth factor (FGF2), Glutamax, human chorionic gonadotropin 
(hCG) and follicle stimulating hormone (FSH). The culture ran for 14 days at 37°C and 5% CO2. In 
paper II, rat testicular single cell suspension was obtained by enzymatic digestion of 7dpp rat testes. 
The single cell suspension was cultured in a three-dimensional (3D) culture system, formed of culture 
medium Dulbecco modified essential medium (DMEM) and agarose 0.7% in 1:1 ratio. The main 
supplements were Glutamax, FSH, and hCG. The culture ran for 31 days at 35°C and 5% CO2. In 
paper III, rat testicular tissue fragments were obtained from 5dpp rat testes and culture using the organ 
culture setup, on agarose stands and using Minimum Essential Medium alpha (MEMα). The main 
supplements included Glutamax, KSR, melatonin, and retinoic acid (RA). The culture ran for 52 days 
at 35°C and 5% CO2. In paper IV, testicular fragments from pre-pubertal boys at high risk to develop 
infertility were obtained by surgical intervention, and cultured in an organ culture system on agarose 
stands using NutriStem® hESC XF Medium and MEMα medium. The main supplements included 
KSR, melatonin and stem cell factor (SCF). The culture ran for 91 days at 35°C and 5% CO2. 
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3.3.2 Three dimensional cell culture (3D) 
In paper II, after decapitation, testes obtained from pre-pubertal rats 7dpp were de-capsulated 
in DMEM containing glutamine (41966, Gibco) and supplemented with1 % pen/strep. To 
obtain single cell suspension, testicular tissue was digested by three-step enzymatic digestion 
using collagenase/Dispase (269638, Roche; final concentration: 0.04/0.32U/ml), DNAse 
(104159, Roche; final concentrations: 48U/ml), and Collagenase IV (C-1889, Sigma-Aldrich; 
final concentrations: 50 U/ml) as described previously (453). The cells were counted in a 
Bürker chamber, and examined for viability by trypan blue staining (15250061, Gibco; 1:20 
dilution). 
The testicular single cell suspension was cultured in agarose-medium matrix, prepared by 
mixing autoclaved 0.7% SeaKem® LE agarose (50004, Lonza, Basel, Switzerland) or 0.7% 
LMP agarose (15517022, Invitrogen, Thermo Fisher Scientific) with the relevant culture 
medium (supplemented with 1% pen/strep) at a ratio of 1:1 to give a final agarose 
concentration of 0.35% agarose, as previously described (Figure 4) (481). The culture media 
investigated in this study included DMEM + glutamine or without glutamine (DMEM-
glutamine; 21969, Gibco), DMEM + Glutamax (31966, Gibco), DMEM/F12 (21331, Gibco), 
F12 (21765, Gibco), and MEM (21430, Gibco). For stimulation, rFSH (Gonal F 75 IE, 
Merck; final concentration: 5 IU/L) and hCG (Pregnyl 5000 IE, Merck Sharpe and Dohme; 
final concentration: 5 IU/L) were used. To investigate their effect on testosterone production, 
amino acids (AA; 11130-036, Gibco) or NEAA (11140-035, Gibco) were added separately to 
F12 medium at a final concentration of 4%, similar to their concentrations in DMEM. The 
single cell suspension was inoculated in the agarose medium matrix with a concentration of 
1.0 x 10
6
 cells/ml. All cell cultures were maintained at 35°C under 5% CO2 and performed in 
triplicates. 
3.3.3 Animal tissue culture 
In paper III, the organ culture technique, as described previously by Sato (489), was used in 
culturing the rat testicular tissue. Agarose stands were prepared by mixing autoclaved 0.7% 
SeaKem® LE agarose with the relevant medium at a ratio of 1:1 to give a final agarose 
concentration of 0.35% agarose. These stands were placed in 6-well plates, with the culture 
medium placed to the level of the top of the stand. Rat testicular tissue was obtained from 5 
dpp rats after decapitation and de-capsulation of the testes in MEMα (22561-021, Gibco) 
culture medium supplemented with 1% pen/strep. Subsequently, testes were cut with sterile 
forceps and scissors into small pieces (≈1mm3 in size for each) and placed on top of the 
agarose stands (Figure 4). In some wells, rat epididymal fat from 5 dpp rats was cut with 
sterile forceps and scissors into small pieces (≈1mm3 in size for each) and placed on top of 
the agarose stand in direct contact with the testicular tissue. The culture medium consisted of 
either MEMα without Glutamax (22561-021, Gibco) or MEMα with Glutamax (32561-029, 
Gibco); both were supplemented with 10% KSR (10828-028, Gibco) and 1% pen/strep. 
Melatonin (M5250, Sigma Aldrich, final concentration 10
-7
 M) or RA (R2625, Sigma 
Aldrich, final concentration 10
-6
 M) or a combination of both was added to the culture 
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medium, depending on the composition intended to investigate if they have an additional 
benefit for germ cell differentiation. The rat testicular tissue was cultured at 34.5°C and 5% 
CO for up to 52 days, and the culture medium was replaced once per week. 
3.3.4 Human tissue culture 
In paper IV, the same organ culture technique, as described previously in the animal tissue 
culture (section 3.3.3), was exploited in culturing the human testicular tissues. In brief, 
testicular tissue was obtained from the patients by an open surgical operation and 20% of one 
testis (testis volume below 10ml) was taken and divided into two pieces; 2/3 of the material 
was further processed for cryopreservation, according to Keros et al 2007 (424), whereas the 
remaining 1/3 of the fresh tissue material was directly used for tissue culture experiments 
described in this study. The tissues were transferred in NutriStem® hESC XF Medium (05-
100-1A, Biological Industries, CT, USA) supplemented with 1% penicillin/streptomycin 
(Pen/Strep; 15140-122, Gibco) on ice within 24 hours after the surgical operation to the lab in 
Karolinska Institutet Hospital in Solna, Sweden. The biopsies were then cut with a sterile 
forceps and a small pair of scissors into small pieces (≈1mm3 in size for each) and processed 
as exactly described in the animal tissue culture (section 3.3.3) as shown in Figure 4. Two 
different culture media, supplemented with 1% Pen/Strep, were used in culturing the 
testicular tissues; MEMα (22561-021, Gibco) and NutriStem® hESC XF Medium. The 
different supplements used included 10% CTS™ KnockOut™ Serum Replacement 
XenoFree Medium (KSR-XF; 12618013, Gibco), melatonin (M5250, Sigma Aldrich, final 
concentration 10
-7
 M), RA (R2625, Sigma Aldrich, final concentration 10
-6
 M), rFSH (Gonal-
f® 75 IE-IU, Merck, final concentration 5 IU/L), testosterone (T1500, Sigma Aldrich, final 
concentration 20ng/ml), and SCF (AF-300-07-10UG, Peprotech, NJ, USA, final 
concentration100ng/ml). The testicular tissues were cultured at 35°C and 5% CO2 for up to 
91 days, as it is expected to take longer time for germ cell differentiation in human than in 
rodents (271), and the culture medium was replaced once per week. 
3.4 STAINING 
3.4.1 Embedding and sectioning 
Samples were fixated either in paraformaldehyde (PFA) 4% in phosphate buffered saline 
(02176, Histolab, Gothenburg, Sweden) or in Bouin’s solution (HT10132, Sigma-Aldrich) 
overnight at 4°C, followed by gradual dehydration in ascending ethanol concentrations 30, 
50, and 70%; each at room temperature overnight. Bouin’s solution gives better fixation for 
soft tissue, such as the testis, as it preserves the structure much better than PFA does (152). 
However, PFA is preferred over Bouin’s solution in case immunostaining is desired, as many 
primary antibodies do not work well with Bouin’s solution fixated samples. Later on, 
samples were dehydrated in ascending ethanol concentrations (80%, 96% and 99.6% 
ethanol), each at room temperature for at least 6 hours. Samples were then transferred in butyl 
acetate (45860, Sigma-Aldrich) overnight at room temperature followed by embedding in 
melted paraffin (ParaplastX-TRAR, P3808, Sigma-Aldrich) at 61°C overnight. Paraffin-
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embedded samples were cut into 5 μm sections after cooling down, using a Biocut sectioning 
machine (Reichert-Jung, NY, USA), and sections were placed on microscope slides 
(10143352, Superfrost Plus, Thermo Scientific, Thermo Fisher Scientific) and dried at 37°C 
overnight. 
For transmission electron microscopy, samples were fixated in 2.5% glutaraldehyde in 0.1 M 
phosphate buffer, pH 7.4, at 4°C. Afterwards, samples were rinsed with the same buffer, post-
fixed in 2% osmium tetroxide in this buffer at 4°C for 2 hours, dehydrated in ethanol and then 
acetone and embedded in LX-112 (Ladd, Burlington, Vermont, USA). Subsequently, Leica 
ultracut UCT (Leica, Wien, Austria) was used to obtain ultra-thin sections (approximately 
40–50 nm thick). 
3.4.2 Periodic acid Schiff staining (PAS) 
PAS staining is used to detect carbohydrates, glycoproteins, and glycolipids in the tissue. 
Periodic acid is an oxidizing agent that oxidizes the glycols groups in sugars to aldehyde 
groups, which condenses with Schiff’s reagent to form a red purple color (504). Sections of 
PFA fixated or Bouin’s solution fixated samples were de-paraffinized in xylene and re-
hydrated in descending ethanol concentration (99.6, 96, and 70%).  Afterwards, PAS kit 
(101646, Merck) was used to stain the sections according to the manufacturer’s protocol. 
After rinsing in distilled water, sections were incubated in periodic acid for 5 minutes, 
followed by rinsing again in distilled water. Later on, sections were incubated in Schiff’s 
reagent for 15 minutes, followed by rinsing in distilled water. Sections were then 
counterstained in hematoxylin (Mayer’s Hemalaun solution, 1092491000, Merck) for 2 
minutes, followed by rinsing under tap water for 3 minutes. Subsequently, sections were de-
hydrated in ascending ethanol concentrations (70, 96, and 99.6%) followed by mounting in 
Entellan® new (1079610100, Merck). When counterstaining was not desired, sections 
proceeded directly to mounting without counterstaining. 
3.4.3 Immunohistochemistry 
In this thesis, beside the regular immunohistochemistry, staining of the apoptotic cells using a 
kit special for apoptosis detection was performed. 
3.4.3.1 Regular immunohistochemistry 
Sections of PFA fixated samples were de-paraffinized in xylene and re-hydrated in 
descending ethanol concentration (99.6, 96, and 70%). Endogenous peroxidase was blocked 
using 0.3% H2O2 in ethanol 96% for 10 minutes at room temperature. After washing in 
washing buffer (phosphate buffered saline (PBS) or Tris buffered saline (TBS)), antigen 
retrieval was performed on the sections, using 0.1% citrate buffer 0.1% TritonX for 8 minutes 
at room temperature, 0.1M citrate buffer (pH 6.0) in the microwave at 600W for 15 minutes, 
or 0.01M citrate buffer 0.05% Tween20 (pH 6.0) for 30 minutes at 95°C. After cooling down 
for 30 minutes and washing again, sections were blocked for non-specific protein binding 
with a blocking buffer, formed of 5-10% normal serum (donkey, horse or goat; depending on 
  41 
the secondary antibody used) and 0.1-1% Bovine serum albumin (BSA) in PBS or TBS, for 
20-30 minutes at room temperature. Sections were then incubated with the primary antibodies 
or immunoglobulins (IgGs; from the same species as the primary antibody) for negative 
control, diluted in the corresponding blocking buffer at 4°C overnight (all the primary 
antibodies used are listed in Table 1). After washing, sections were incubated with the 
biotinylated secondary antibodies diluted in the same blocking buffer at room temperature for 
1-2 hours (all the secondary antibodies and sera used are listed in Table 2). Afterwards, 
sections were washed and Vectastain ABC elite Standard kit (PK-6100, Vector labs, CA, 
USA) was applied on the sections according to the manufacturer’s protocol. After washing, 
ImPACT™ DAB (3, 3'-Diaminobenzidine) kit (SK-4105, Vector labs) was used for detection 
according to the manufacturer’s protocol. Sections were then counterstained with 
hematoxylin (Mayer’s Hemalaun solution, 1092491000, Merck) for 5 seconds and washed in 
running tap water for 2 minutes. Later on, sections were dehydrated using ascending ethanol 
concentrations followed by xylene, and mounted finally in Entellan® new (1079610100, 
Merck). 
3.4.3.2 Staining of the apoptotic cells 
The Terminal deoxynucleotidyl transferase dUTP nick end-labeling TUNEL Assay kit 
(DeadEnd™ Colorimetric Tunel System, G7130, Promega, WI, USA) was used to detect the 
apoptotic cells according to the manufacturer’s protocol. The kit is specified to detect the 
fragmented DNA, which is the end result of apoptosis (505). In brief, sections of PFA fixated 
samples were de-paraffinized and re-hydrated as previously mentioned in the 
immunohistochemistry section (3.4.3). Later on, sections were treated with proteinase-k and 
then incubated with biotinylated nucleotide mix + rTDT enzyme + enzyme buffer at 37°C for 
one hour. Afterwards, sections were washed, incubated with streptavidin-HRP (horseradish 
peroxidase) complex, and detected with DAB. Sections were then counterstained with 
hematoxylin, dehydrated in ascending ethanol concentrations and mounted in Entellan® new 
mounting medium. 
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Table 1. A list of all the primary antibodies used in the thesis. 
 Antibody Origin Concentration 
in µg/ml 
Catalogue 
and company 
Paper 
1 Ddx4 Rabbit 
polyclonal 
2-10 Ab13840, 
Abcam, 
Cambridge, 
UK 
I, II and III 
2 Ddx4 Mouse 
monoclonal 
2 Ab27591, 
Abcam 
IV 
3 Vimentin Rabbit 
polyclonal 
50 Ab8545, 
Abcam 
I 
4 Vimentin  Rabbit 
monoclonal 
2-5 Ab92547, 
Abcam 
II 
5 3βHsd Mouse 
monoclonal 
2 Sc-100466, 
Santa Cruz, 
Texas, USA 
I 
6 3βHsd Rabbit 
polyclonal 
1 Sc-28206, 
Santa Cruz 
II 
7 AMH Rabbit 
polyclonal 
5 Ab103233, 
Abcam 
I 
8 SOX9 Rabbit 
polyclonal 
2-5 AB5535, 
Millipore, 
Billerica, 
Massachusetts, 
USA 
I and IV 
9 WT-1 Rabbit 
polyclonal 
2-5 Ab89901, 
Abcam 
I and IV 
10 INSL3 Rabbit 
polyclonal 
4 Sc-134586 I 
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11 AP2γ Rabbit 
polyclonal 
2 Sc-8977, 
Santa Cruz 
II 
12 Crem Rabbit 
polyclonal 
0.5-1 Sc-440, Santa 
Cruz 
III 
13 Acrosin Rabbit 
polyclonal 
4 NBP2-14260, 
Novus 
Biologicals, 
Minneapolis, 
USA 
III 
14 Ki67 Rabbit 
polyclonal 
5 Ab16667, 
Abcam 
II and III 
15 POU5F1 
(OCT4) 
Goat 
polyclonal 
4 Sc-8629, 
Santa Cruz 
I 
16 IgGs Rabbit Depending on 
the primary 
antibody 
Ab27478, 
Abcam 
I, II, III and 
IV 
17 IgGs Rabbit Depending on 
the primary 
antibody 
Sc-2027, 
Santa Cruz 
I and II 
18 IgGs Mouse Depending on 
the primary 
antibody 
Sc-2025, 
Santa Cruz 
I and IV 
19 IgGs Goat Depending on 
the primary 
antibody 
Sc-2028, 
Santa Cruz 
I 
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3.4.4 Immunofluorescence 
In this thesis, we have performed single immunofluorescence and double 
immunofluorescence. 
3.4.4.1 Single immunofluorescence 
Sections of PFA fixated samples were treated as previously described in the 
immunohistochemistry section (3.4.3), till the incubation with the primary antibodies. 
Subsequently, sections were incubated with either Cy3- or Alexa Fluor 488-conjugated 
secondary antibodies, diluted in the blocking buffer used in blocking of the non-specific 
protein binding, for 30-60 minutes at room temperature (all secondary antibodies and sera are 
listed in Table 2). After washing, sections were mounted in VECTASHIELD mounting 
medium with DAPI (4',6-Diamidino-2-Phenylindole; H-1500, Vector labs). 
3.4.4.2 Double immunostaining 
The protocol developed by van den Driesche and colleagues (506)  was exploited, as it has 
the privilege of using two primary antibodies simultaneously from the same species. As 
previously described in the immunohistochemistry section (3.4.3), sections of PFA fixated 
samples were treated till the antigen retrieval step. After antigen retrieval, sections were 
blocked for endogenous peroxidase using 3% H2O2 in methanol for 30 minutes at room 
temperature. Afterwards, blocking of non-specific protein binding was performed using 20% 
normal chicken serum 5% BSA in TBS for 30 minutes at room temperature. Sections were 
then incubated with the primary antibodies or IgGs for negative control at 4°C overnight. 
After washing, sections were incubated with HRP-conjugated chicken secondary antibodies 
against the same species from the primary antibodies for 30 minutes at room temperature. 
Later on, sections were washed and the TSA™ Plus Fluorescein System (NEL741001KT, 
Perkin Elmer Life Sciences, Waltham, Massachusetts, USA) was applied according to the 
manufacturer’s protocol. Antigen retrieval was repeated once more and sections were 
incubated with 3% H2O2 in TBS-Tween 0.01% for 30 minutes at room temperature. Later on, 
sections were incubated again as previously mentioned with the primary antibodies or IgGs 
for negative control, washed, incubated with the HRP-conjugated chicken secondary 
antibodies. After washing, TSA™ Plus Cyanine 3 System (NEL744001KT, Perkin Elmer 
Life Sciences) was applied according to the manufacturer’s protocol and the sections were 
mounted in VECTASHIELD mounting medium with DAPI (H-1500, Vector labs). 
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Table 2. A list of all the secondary antibodies listed in the thesis. 
 Secondary 
antibody 
origin 
Against Conjugation Concentration 
in µg/ml 
Catalogue, 
company 
Paper 
1 Goat Rabbit 
IgG 
Biotin 5 BA1000, Vector 
labs 
I 
2 Horse Goat 
IgG 
Biotin 5 BA9500, Vector 
labs 
I 
3 Horse Mouse 
IgG 
Biotin 5 BA200, Vector 
labs 
I 
4 Chicken Rabbit 
IgG 
HRP 2 Sc-2963, Santa 
Cruz 
I, II and 
III 
5 Donkey Rabbit 
IgG 
Cy3 2.5-5 711-166-152, 
Jackson 
Immunoresearch, 
PA, USA 
I, II, III 
and IV 
6 Donkey Mouse 
IgG 
Alexa Fluor 
488 
4.6 715-546-150, 
Jackson 
Immunoresearch 
IV 
7 Goat Rabbit 
IgG 
Biotin 5 Ab64256, 
Abcam 
II and 
III 
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3.5 MICROSCOPY, MORPHOLOGIC, AND HISTOLOGICAL EVALUATION 
3.5.1 Transmission electron microscopy (TEM) 
After preparation of the ultrathin sections, they were contrasted by uranyl acetate and then 
lead citrate and examined under a Tecnai 12 Spirit Bio TWIN transmission electron 
microscope (FEI Company, Eindhoven, Netherlands) at 100 kV. Capturing of the digital 
images was done using a Veleta camera (Olympus Soft Imaging Solutions, GmbH, Münster, 
Germany). For identification of the different cell shape, locations, and size; the criteria 
formulated by Sathananthan and colleagues were followed (507). 
3.5.2 Microscopy for immunostaining and PAS staining 
All stained sections were examined under the microscope (Eclipse E800; Nikon, Tokyo, 
Japan) with a 12.5 million-pixel, cooled digital color camera (Olympus DP70, Olympus 
Optical, Tokyo, Japan). The different cell types were identified on the basis of size, shape and 
location, according to Russel and colleagues (152). 
3.5.3 Time lapse 
Time lapse was taken using an Eclipse TE200 (Nikon) microscope, with the pictures taken 
with an Infinity1 camera (Lumenera, Ontario, Canada). Frames for the time lapse were taken 
every one second and represented in the videos with the real-time pace. 
3.5.4 hES cells photography 
hES cells photography was performed using a Nikon SMZ-U microscope (Nikon) with an 
Infinity 1 camera (Lumenera). 
3.5.5 Morphologic and histological evaluation 
In paper I, evaluation of DDX4- and SOX9-expressing cell colonies was done by manual 
examination of at least 45 cell colonies from each cell line. 
In paper II, the apoptotic rate was calculated as a ratio of the TUNEL-positive cells (apoptotic 
cells) to the total number of cells in a section. At least, 500 cells for each sample were 
counted, and the rate was expressed relative to the rate on the first day of culturing, in order 
to avoid the effect of the different culture techniques. 
In paper III, the evaluation of Ddx4/Ki67 double staining was done by counting the number 
of tubules containing Ddx4 positive/Ki67 positive cells per the total number of tubules in a 
section (germ cell proliferation index) and was compared in two culture conditions (MEMα + 
10% KSR ± Glutamax). Then, 60 to 80 tubules were counted for each culture condition. For 
the evaluation of Ddx4/Crem staining, the number of tubules containing Ddx4 positive/Crem 
positive cells per the total number of tubules in a section was counted and compared across 
the different culture conditions. A total of 100 to 450 tubules were counted for each 
condition. For the evaluation of Acrosin staining, the number of tubules containing Acrosin 
positive cells per the total number of tubules in a section was counted and compared within 
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the different culture conditions. A total of 100 to 450 tubules were counted for each setting. 
For the morphologic evaluation, the number of tubules containing primary spermatocytes or 
round spermatids per the total number of tubules in a section was used as an index for the 
germ cell differentiation progress. The total number of tubules counted per culture condition 
varied between 80 and 180 tubules. For the gross morphologic evaluation, 4X pictures of the 
PAS stained sections were taken and the necrotic region in a section was identified and 
quantified relative to the total surface area of the same section (as a percentage) using the 
ImageJ software (National Institutes of Health, USA). A number of 3 to 9 biological 
replicates were recruited from each culture condition for statistical analysis, and the 
percentage of necrotic area was compared between the different conditions. 
In paper IV, the necrotic area calculation was performed by taking 4X pictures of the PAS 
stained sections, and then, surface area of the necrotic region in a section was identified and 
quantified in relation to the total surface area of the same section (as a percentage) using the 
ImageJ software (National Institutes of Health, USA). 
3.6 GENE EXPRESSION ANALYSIS 
3.6.1 RNA extraction and cDNA amplification 
Samples taken were snap frozen in dry ice and stored at -80°C till RNA extraction was 
performed. For RNA extraction, TRIzol® Reagent (15596-018, Invitrogen, Thermo Fisher 
Scientific) and RNeasy Mini Kit (74104, Qiagen, Venlo, Netherlands) were utilized 
according to the manufacturer’s protocol. The TRIzol® reagent depends on 
guanidine/isothiocyanate/phenol/chloroform extraction method, which separates the RNA 
from DNA and proteins (508). The RNA isolated was treated with DNase1 Amplification 
Grade (AMPD1, Sigma-Aldrich) to eliminate the genomic DNA contamination. For cDNA 
amplification, the IScript cDNA synthesis kit (170-8891, Bio-Rad, CA, USA) was applied 
according to the manufacturer’s protocol. 
3.6.2 Reverse transcriptase-polymerase chain reactions (RT-PCRs) 
In this technique, the mRNA of interest is reverse transcribed by reverse transcriptase into 
cDNA, which is amplified by PCR and then detected as a band by gel electrophoresis (509). 
The presence of the band means that the gene is expressed, while the absence of the band 
means the gene is not expressed. In order to perform RT-PCR analysis, the Expand High 
Fidelity PCR System (11759078001, Roche) was applied, using the 2710 Thermal Cycler 
(Applied Biosystems, Thermo Fisher Scientific). Primers specific for messenger RNAs 
considered to be consensus markers for undifferentiated hES cells were used, along with 
ACTB (beta actin) as an endogenous control. A list of all the primers used for gene expression 
analysis by the RT-PCR technique is included in Table 3, including GABRB3 (Gamma-
Aminobutyric Acid Type A Receptor Beta3 Subunit). 
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Table 3. A list of all the primers used in gene expression analysis by RT-PCR technique. 
Fw: forward, Rev: reverse. 
 Gene Species Sequence 5´→3 Paper 
1 NANOG Human Fw: CAAAGGCAAACAACCCACTT 
Rev: CTGGATGTTCTGGGTCTGGT 
I 
2 POU5F1 Human Fw: GACAACAATGAAAATCTTCAGGAGA 
Rev: TTCTGGCGCCGGTTACAGAACCA 
I 
3 TDGF1 Human Fw: AGCACAGTAAGGAGCTAAACA  
Rev: CAGTTCCGTCCGTAGAAGGAG 
I 
4 GDF3 Human Fw: GTACTTCGCTTTCTCCCAGAC  
Rev: GCCAATGTCAACTGTTCCCTT 
I 
5 GABRB3 Human Fw: CAAGCTGTTGAAAGGCTACGA  
Rev: ACTTCGGAAACCATGTCGATG 
I 
6 ACTB Human Fw: CCTGGCACCCAGCACAAT  
Rev: GGGCCGGACTCGTCATAC 
I 
 
 
  
  49 
3.6.3 Quantitative PCR (qPCR) 
The iCycler iQ™ multicolor RT-PCR detection system (Bio-Rad) was utilized to perform the 
qPCR, while the iCycler iQ® ver.3.1 software (Bio-Rad) was used in data analysis. Two 
main technologies were used in this thesis to perform qPCR; the TaqMan technology 
(Applied Biosystems) and SYBR® green technology (Bio-Rad). The TaqMan technology is 
based on a pre-designed probe for a specific gene. This probe has a reporter dye at its 5’ end 
and a quencher at its 3’ end. When the probe is at rest, the quencher is close enough from the 
dye that it is not detected, while when the probe binds to the template and amplification 
process starts, the reporter dye becomes free and then it can be detected. The more DNA 
amplified, the more reporter dye detected (510). For the SYBR® green technology, it 
depends on the binding of a fluorescent dye to the double stranded DNA. The dye can only be 
detected once bound to the DNA. The more DNA amplified, the more fluorescent dye 
detected (511). For these two technologies, the TaqMan Gene Expression Master Mix 
(4369510, Applied Biosystems) and the iQ SYBR® Green Super mix (170–8882, Bio-Rad) 
were used respectively. All primers and probes of the genes used in gene expression analysis 
by the SYBR® green technology and by the TaqMan technology are listed in Table 4 and 
Table 5 respectively. As an endogenous control, Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) was used in paper I for the ES cells, while Actb was used in paper 
II and III for the rat testicular cells. The comparative ddCt (threshold cycle) method was used 
in expressing he fold of change in gene expression (2
-ddCt
). 
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Table 4. A list of all the primers used in gene expression analysis by qPCR using SYBR® 
green technology. Fw: forward, Rev: reverse. 
 Gene Species Sequence 5´→3 Paper 
1 POU5F1 Human Fw: GACAACAATGAAAATCTTCAGGAGA  
Rev: TTCTGGCGCCGGTTACAGAACCA 
I 
2 KIT Human Fw: GGCATGCTCCAATGTGTGG  
Rev: GGTGTGGGGATGGATTTGC 
I 
3 GAPDH Human Fw: GAAGGTGAAGGTCGGAGTCAAC  
Rev: CAGAGTTAAAAGCAGCCCTGG 
I 
4 Star Rat Fw: CTGCTAGACCAGCCCATGGAC 
Rev: TGATTTCCTTGACATTTGGGT 
II 
5 Tspo Rat Fw: GCTATGGTTCCCTTGGGTCT 
Rev: GGCCAGGTAAGGATACAGCA 
II 
6 Actb Rat Fw: TGAAGATCAAGATCATTGCTC 
Rev: ACTCATCGTACTCCTGCTTGC 
II 
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3.6.4 TaqMan Low-Density Arrays (TLDAs) 
TLDA technology is based on a microfluidic card, pre-designed to have 90 probes, based on 
the TaqMan technology, distributed in 90 wells to detect genes specific for undifferentiated 
ES cells or their differentiated derivatives, along with 6 endogenous control genes (512). In 
paper I, TLDA cards (4385344, Applied Biosystems), designed for International Stem Cell 
Initiative (16), were used to evaluate the gene expression profile of the three cell lines 
cultured on feeders or in spheres. A total of 90 genes, in addition to 6 control genes, where 
investigated. The control genes used were GAPDH, ACTB, RAF1, CTNNB1 (Catenin Beta 1), 
EEF1A1 (Eukaryotic Translation Elongation Factor 1 Alpha 1) and 18S, as these genes were 
suggested to be the most stable ones when analyzing gene expression in hES cells (16). Mean 
values of the replicates were used for heat maps and clustering analysis (Euclidean distance 
with complete linkage) using GENE-E software. 
(http://www.broadinstitute.org/cancer/software/GENE-E/index.html). 
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Table 5. A list of all the probes used in gene expression analysis by qPCR using TaqMan® 
technology. 
 Gene Species Assay ID Paper 
1 NANOG Human Hs02387400_g1 I 
2 DDX4  Human Hs00251833_m1 I 
3 FSHR Human Hs00174865_m1 I 
4 VIM Human Hs00185584_m1 I 
5 HSD3B1 Human Hs04194787_g1 I 
6 INSL3 Human Hs01394273_m1 I 
7 GAPDH Human Hs02758991_g1 I 
8 Acr  Rat Rn01407524_m1 III 
9 Crem Rat Rn01538528_m1 II and III 
10 Prm1 Rat Rn02345725_g1 II and III 
11 Sycp3 Rat Rn01648688_m1 III 
12 Boll Rat Rn01441407_m1 II and III 
13 Kit Rat Rn00573942_m1 II and III 
14 Zbtb16 Rat Rn01418644_m1 II and III 
15 Dazl  Rat Rn01757162_m1 II and III 
16 Ddx4 Rat Rn01489814_m1 III 
17 Actb Rat Rn00667869_m1 II and III 
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3.7 HORMONAL ASSAY 
In order to investigate the somatic cell environment functionality in vitro (e.g. Leydig cells 
and Sertoli cells) we have performed hormonal assays to evaluate the testosterone and Inhibin 
B production. 
3.7.1 Testosterone assay 
To evaluate the testosterone production, testosterone was extracted from the tissue and 
medium samples using ethyl acetate. Steroids (e.g. testosterone) diffuse form the aqueous 
phase into the organic phase (ethyl acetate). After separation of the two phases and 
evaporation of the ethyl acetate, the residue was re-suspended in PBS and testosterone was 
evaluated by either radioimmunoassay or enzyme linked immunosorbent assay. 
3.7.1.1 Testosterone radioimmunoassay (RIA) 
The RIA kit for testosterone evaluation is based on using tubes pre-coated with testosterone 
antibodies. When testosterone form in samples is incubated with the I
125
 testosterone, both 
types of testosterone compete on these antibodies. The higher the testosterone concentration 
in the sample, the lower the radioactivity bound to the coated tube. By measuring the 
radioactivity in the tube, we can determine the concentration of testosterone, in relation to a 
standard curve (513). The COAT-A-COUNT1 kits (TKTT2, Siemens, Munich, Germany) 
was used in accordance with the manufacturer’s protocol to evaluate testosterone production. 
The extracted testosterone was incubated with I
125
 testosterone at 37°C for 3 hours in special 
coated tubes. After decantation of the mixture, the radioactivity in the tube was counted in a 
Gamma counter (1470 Wizard Wallac, GMI, Ramsey, MN, USA) for one min. The standards 
provided with the kits (0–55 nmol/L) were used for calibration. 
3.7.1.2 Testosterone Enzyme Linked Immunosorbent Assay (ELISA) 
In this assay, the testosterone in the sample competes with testosterone-HRP conjugate 
supplied with the kit on binding to the plates that were pre-coated with testosterone antibody. 
Hence, the higher the testosterone concentration, the lower the color detected. The 
testosterone ELISA kit (EIA-1559, DRG instruments, Marburg, Germany) with an intra-
assay CV < 5% and inter-assay CV < 10% was used according to the manufacturer’s protocol 
to perform the assay. The microplate reader Fluostar Omega (BMG LabTech, Ortenberg, 
Germany) was used for reading the absorbance at 450nm, while the standards provided with 
the kit were used for generating a standard curve. 
3.7.2 Inhibin B Gen II ELISA 
Inhibin B is composed of 2 subunits; subunit βB and subunit α. Inhibin B shares with inhibin 
A the subunit α, while they differ in the subunit β (βB for inhibin B and βA for inhibin A). On 
the other hand, inhibin B shares with activin B the subunit βB. Hence, to evaluate inhibin B 
production, a sandwich ELISA is applied to detect the inhibin B (514). The ELISA kits for 
Inhibin B Gen II (A81303, Beckman Coulter, CA, USA) with an intra-assay CV < 5% and 
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inter-assay CV < 10% was used to evaluate inhibin B levels, utilizing calibrators and controls 
(A81304, Beckman Coulter) in accordance with the manufacturer’s recommendations. 
Samples are incubated with plates pre-coated with antibody for the βB subunit. Then, the 
plates are incubated with biotinylated antibody for the subunit α. Later on, streptavidin-HRP 
conjugate is applied and the color is developed with a substrate and the absorbance is 
measured at 450 nm. 
3.8 STATISTICS 
In paper I, the unpaired t-test was used with a two-tailed p value (Prism 6, GraphPad 
Software, Inc., CA, USA) was used in TLDA array statistical analysis, while one way 
ANOVA (analysis of variance) was used with the Bonferroni multiple comparison test (Prism 
6, GraphPad Software, Inc., CA, USA) in comparing all cell lines and culture conditions. To 
compare values under the different experimental conditions, One-Way RM ANOVA 
(SigmaPlot 11.0; Systat Software Inc., CA, USA) was used. Following the Shapiro–Wilk test 
for normality, pair-wise multiple comparisons were performed with Holm–Sidak or 
Dunnett’s procedure (SigmaPlot 11.0; Systat Software Inc.; CA, USA), as indicated in the 
figure legends. A p-value of ≤ 0.05 was considered statistically significant. 
In paper II, III and IV, Student’s t -test, One-way ANOVA, One-way RM ANOVA and 
ANOVA on ranks were used to compare the differences between experimental conditions 
(SigmaPlot11.0; Systat Software Inc., CA, USA). Pairwise multiple comparisons were 
performed with the Holm–Sidak procedure following the Shapiro–Wilk test for normality, as 
stated in the Figure legends (SigmaPlot 11.0; Systat Software Inc.). A difference was 
considered to be statistically significant if the p value was ≤ 0.05. 
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4 RESULTS AND DISCUSSION 
4.1 DIFFERENTIATION POTENTIAL OF HUMAN ES CELLS TOWARDS MALE 
GERM CELLS (PAPER I) 
It has been reported that the different hES cell lines have different tendencies regarding 
differentiation potential towards the germ cell lineage (93). Since hES cell lines do not share 
an indistinguishable gene expression profile (16), we aimed in this study to investigate the 
possibility of using the gene expression profile of the hES cell line to predict its 
differentiation potential towards the germ cell lineage. The hES cells were cultured in 
conventional feeder layer culture and in suspension. The reason the suspension culture was 
investigated is that it has been reported before to support the differentiation of ES cells to the 
neural cell lineages, as it gives the spatial support to the differentiated cells (72). Hence, 
whether the sphere culture supports the differentiation of the ES cells to germ cells needs to 
be investigated. 
4.1.1 Undifferentiated hES cell lines exhibit different gene expression 
profiles in the different culture conditions 
The three hES cell lines used in this study (HS207, HS360 and HS401) were cultured either 
on hFFs or as spheres in suspension culture. All of the cell lines expressed the pluripotency 
consensus markers in both culture conditions. Using the TLDA cards, the expression of 90 
genes, related to pluripotency and differentiation assessment, were investigated for the three 
cell lines cultured in both conditions. The samples exhibited clustering in favor of the culture 
condition rather than the cell line, indicating that the gene expression profile is affected 
mainly by the different culture conditions, rather than by the cell line. When the three hES 
cell lines were cultured as spheres in suspension culture, 17 genes were significantly 
downregulated and 23 genes were significantly upregulated, compared to the three cell lines 
when cultured on feeders. Among the upregulated genes, we have found the stem cell 
markers SOX2, KIT, FGF4, and LIN28 and the endodermal marker SOX17, while among the 
downregulated ones, we have found FGF5 and Galanin and GMAP Prepropeptide (GAL). 
Some ectoderm markers (Paired Box 6 (PAX6), Oligodendrocyte Lineage Transcription 
Factor 2 (OLIG2), and Neuronal Differentiation 1 (NEUROD1)) were upregulated in the 
suspension culture compared to the culture on feeders, which could be due to supplementing 
the suspension culture with neurotrophic factors (rBDNF and rNT3), while we could not 
detect any of the ectoderm markers to be downregulated in the suspension culture compared 
to the culture on feeders. 
One of the important signaling pathways in germ cell specification we investigated was the 
NODAL/ACTIVIN pathway. When the two culture conditions were compared in each cell 
line separately, EBAF and NODAL showed significant lower expression in the suspension 
culture compared to the culture on feeders in the cell lines HS207 and HS401, while GDF3 
(Growth Differentiation Factor 3) showed significant lower expression in the suspension 
culture compared to the culture on feeders in the cell lines HS360 and HS401. Nevertheless, 
LEFTB was significantly downregulated in the suspension culture compared to the culture on 
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feeders in all cell lines, whereas Teratocarcinoma-Derived Growth Factor 1 (TDGF1) was 
significantly upregulated in suspension culture in HS207 cell line, and significantly 
downregulated in suspension culture in HS401 cell line, both compared to the culture on 
feeders. The early germ cell markers (SOX2, KIT and LIN28) were significantly upregulated 
in all cell lines in the suspension culture compared to the culture on feeders. Meanwhile, 
FGF4 was significantly upregulated in the suspension culture in the cell lines HS360 and 
HS401, and SOX17 was significantly upregulated in the suspension culture in the HS270 cell 
line, when both were compared with the culture on feeders. In other words, the HS360 had 
the most stable NODAL/ACTIVIN pathway compared to the other two cell lines, while 
keeping an upregulated germ cell markers expression. 
4.1.2 Absence of FGF2 in hES cell culture medium has different effects on 
gene expression profile depending on the culture condition 
We have used two culture methods to achieve spontaneous differentiation of the three hES 
cell lines; differentiation on a feeder layer and differentiation in spheres. Since spontaneous 
differentiation on feeders was reported previously (93,111), this culture method was used as a 
control for the suspension method. The growth factor FGF2 was reported previously to be 
important for maintaining the pluripotency of hES cells, and the deprivation of pluripotent 
cells from this factor resulted in spontaneous differentiation of the hES cells (54,93). Hence, 
we have used this technique to achieve a spontaneous differentiation of the three hES cell 
lines used. However, depriving the cells cultured on feeders from FGF2 did not reduce 
significantly the expression of the pluripotency markers NANOG and POU5F1 in any of the 
three cell lines used, which indicated that the differentiation was partly unsuccessful. A 
plausible explanation for that could be the FGF2 and Activin produced by the hFF cells, both 
of which has a supportive role in the expression of pluripotency genes (63,135,515). On the 
other hand, deprivation of the three cell lines cultured on feeders from FGF2 resulted in 
upregulation of DDX4 expression in the cell lines HS360 and HS401, upregulation of KIT in 
the HS207 cell line, and downregulation of KIT in the HS360 cell line. Meanwhile, the 
expression of the Sertoli cell markers FSHR and vimentin (VIM) was not changed after the 
spontaneous differentiation. 
Spontaneous differentiation in the suspension culture was achieved by culturing the hES cell 
spheres from the three cell lines in un-supplemented medium without passaging. Herein, the 
expression of POU5F1 was downregulated in the three cell lines, whereas the expression of 
NANOG was downregulated only in the HS360 cell line. Surprisingly, the expression of the 
germ cell marker DDX4, the Sertoli cell markers VIM and FSHR, and the Leydig cell markers 
Insulin-Like 3 (INSL3) and 3β-Hydroxysteroid dehydrogenase (HS3BD1) was not altered in 
any of the three cell line after the spontaneous differentiation in suspension culture. Using 
TEM, the morphologic characteristics of the hES cells after spontaneous differentiation in 
suspension were not uniform; some cells exhibited the characteristics of undifferentiated hES 
cells and others exhibited the characteristics of differentiated hES cells. 
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4.1.3 BMP7 stimulates differentiation of hES cells in suspension towards 
putative male gonadal cells 
It has been reported previously that BMPs promote the differentiation of the pluripotent cells 
towards the germ cell lineage (109,113,128). Thus, we tried to induce the differentiation of 
the three cell lines with BMP7 in both culture methods; on feeders and in suspension. When 
the three cell lines were cultured on feeders, BMP7 stimulation did not result in 
downregulation of the pluripotency markers NANOG and POU5F1 in any of the three cell 
lines. We also found that the expression of DDX4 was upregulated in the HS360 and HS401 
cell lines, while the expression of KIT was upregulated in the HS207 and HS401 cell lines. 
As for the Sertoli cell markers, FSHR expression was significantly upregulated in the HS207 
cell line, whereas VIM was downregulated in the cell lines HS207 and HS401. 
When the spheres were differentiated in suspension culture, BMB7 stimulation resulted in 
significant downregulation in the expression of the pluripotency markers NANOG and 
POU5F1 in the three cell lines. In addition, DDX4 expression was significantly increased in 
the HS360 and HS401 cell lines, whereas KIT expression was significantly increased in the 
HS360 cell line. As for the Sertoli cell markers, FSHR was significantly upregulated in the 
HS360 cell line, while VIM was significantly upregulated in the HS207 and HS401 cell lines. 
In regards to the Leydig cell markers, INSL3 was significantly upregulated in the HS207 cell 
line, and the HS3BD1 was significantly upregulated in the HS360 cell line. The 
downregulation of the pluripotency genes, along with the upregulation in the gonadal cells 
markers, could be an indication that BMP7 induces the differentiation towards gonadal cells 
in suspension culture, which was not the case with the hES cells cultured on hFFs. 
4.1.4 Assessment of protein expression in suspension culture after 
spontaneous differentiation and BMP7 stimulation 
When the three cell lines were cultured in suspension, they were either spontaneously 
differentiated or BMP7 stimulated. To compare between both methods, assessment of protein 
expression of certain markers by immunofluorescence was performed. The expression of 
SOX9, a Sertoli cell marker, showed a characteristic pattern of cell colonies surrounded by 
cytoplasmic SOX9 positive cells. With spontaneous differentiation, only the HS401 cell line 
had 5.0% of colonies positive for SOX9, while with BMP7 stimulation, the HS207 cell line 
had (14.9%), the HS401 cell line had (11.8%), and the HS360 cell line had (1.5%) of colonies 
positive for SOX9. When the expression of Wilms tumor gene 1 (WT-1), another Sertoli cell 
marker, was evaluated, it revealed a very similar pattern for the SOX9 expression (edges of 
colonies with both methods of differentiation). However, WT-1 expression was nuclear and 
occurred in all cell lines, regardless to the BMP7 stimulation. 
DDX4 expression, the germ cell marker, was observed in all cell lines after both methods of 
differentiation in suspension; spontaneous differentiation and BMP7 stimulation. However, 
the HS360 cell line was the only cell line that showed an increased percentage of the DDX4-
positive cells in the colonies expressing DDX4 after BMP stimulation. Thus, the cell line 
HS360 was investigated more by immunohistochemistry for some markers. We found that 
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POU5F1, DDX4, VIMENTIN, AMH, INSL3 and HS3BD1 were expressed in the spheres of 
HS360 cell line after differentiation using BMP7 stimulation. 
4.1.5 Putative Sertoli and Leydig cells do not secrete hormones at this stage 
of differentiation 
To assess the functionality of the cells assumed to be Sertoli cell-like or Leydig cell-like cells, 
testosterone and inhibin B production in the culture medium was evaluated. The results 
revealed that the testosterone could be detected at an extremely low level (3.82 ± 0.63 
pmol/L), while inhibin B could not be detected (limit of detection was 10 ng /L). 
4.1.6 Discussion 
The reason behind using hES cells is that it is crucial to study the early germ cell 
developmental stages in order to establish a robust system to differentiate the human germ 
cells in vitro to mature gametes. However, the difficulties in performing such studies, along 
with the differentiation potential of hES cells towards the different cell lineages, encouraged 
the researchers to study the hES cells differentiation towards germ cells in vitro as a model 
for the early germ cell development. 
Differentiation of stem cells, albeit in low efficiency, towards germ cells has been reported 
earlier (93,108,111,114). It has also been reported that the suspension culture can maintain 
the pluripotent state of the hES cells (72). Moreover, the suspension culture supported the 
differentiation towards the neural cell lineage; due to the spatial 3D support it gives to the 
culture. Hence, we tried here to investigate the effect of using different cell lines of hES cells 
and different culture conditions (on hFF feeders or in suspension) on the gene expression 
profile and the differentiation potential of the hES cells. When three different hES cell lines 
were examined, the gene expression profile for each one of them was, albeit similar, not 
identical to the other in the same culture condition, and the gene expression profile was also 
different for the same cell line when cultured in two different conditions. This indicated that 
the culture conditions could have an effect on the gene expression profile of hES cells, and 
hence, could have an effect on its differentiation potential. 
On the other hand, NODAL/ACTIVIN signaling pathway has been reported earlier to be of 
great importance to germ cell lineage specification (138-140,516,517). In the early gonadal 
development, NODAL/ACTIVIN signaling ensures that the PGCs do not enter meiosis and 
stay undifferentiated to develop towards the male gonocytes (138). Meanwhile, EBAF and 
LEFTB inhibit NODAL, whereas TDGF1 and GDF3 activate this pathway (517-519). In this 
study, the pivotal genes involved in this pathway (EBAF, TDGF1, LEFTB, NODAL and 
GDF3) were found to be differently expressed between the hES cell lines and the different 
culture conditions. When the cell lines HS207 and HS401 were cultured in suspension, the 
NODAL/ACTIVIN pathway seemed mainly downregulated, while when the HS360 cell line 
was cultured under the same conditions, the NODAL/ACTIVIN pathway was more stable. 
Thus this cell line was expected to be the most promising among the three cell lines to 
differentiate towards male gonadal cells. In the same context, other genes, important for male 
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germ cell development, were found to be upregulated in the HS360 cell line, such as LIN28, 
KIT and SOX2 (520-523). 
Surprisingly, depriving the hES cells from exogenous FGF2 did not result in a reduction the 
pluripotency genes expression when the cells were cultured on feeders, while it could reduce 
the expression of such genes when the cells were cultured in suspension. This could be due to 
the fact that the hFF cells secrete interleukin 6 (IL6) and FGF2, which were reported earlier 
to be enough for keeping the hES cell pluripotent in culture (63,515). 
Although DDX4 gene expression was detected in the undifferentiated state, which was also 
reported earlier (16,93,108,110,113), DDX4 protein was only detected in the BMP7 
stimulated differentiated cells. In general, the suspension culture, with or without BMP 
stimulation resulted in an upregulation of the genes specific for Sertoli cell and Leydig cell. 
Sertoli cells have an important role in sex determination and germ cell development 
(524,525). Two of the main markers for Sertoli cells have been detected on protein level after 
differentiation in this study; SOX9 and WT-1. Both markers are expressed in the immature 
Sertoli cells and are important for Sertoli cell differentiation (526,527). Other Sertoli cell 
markers that have been detected on protein levels with immunohistochemical staining 
included VIM and AMH (158,528). Moreover, Leydig cell markers, INSL3 and HSD3B1 
(187,529,530) have been detected on protein level in the differentiated cells as well. When 
the functionality of these putative cells was investigated by evaluating the testosterone and 
inhibin B production, there was extremely low levels of testosterone and non-detectable 
levels of inhibin B, this could be due to that the cells did not secrete testosterone and inhibin 
B, or there were too few functional cells. 
Taken together, the gene expression profile of hES cells depends on the cell line and the 
culture conditions. In addition, BMP7 stimulation resulted in upregulation in the germ cell 
markers KIT and DDX4 and somatic cell markers FSHR and HS3BD1, with a downregulation 
in the pluripotency markers NANOG and POU5F1. 
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4.2 EFFECT OF CULTURE CONDITIONS ON RAT GERM CELL MATURATION 
IN VITRO IN 3D CULTURE (PAPER II) 
The effect of the culture medium in 3D culture conditions on rat germ cell maturation in vitro 
has not studied yet. Thus, we have employed the 3D agarose culture system we used earlier 
with mouse testicular cell culture (480) to culture the rat pre-pubertal testicular cells, aiming 
at optimizing the culture conditions, in regards to the culture medium and gonadotropin (hCG 
and FSH) stimulation. 
4.2.1 Effect of the culture media and gonadotropins on testosterone 
production by rat Leydig cells in a 3D culture system 
When we used gonadotropins in stimulating the rat pre-pubertal testicular cells in a 3D 
culture system, it resulted as expected in an increased production of testosterone after 24 
hours. However, the DMEM + glutamine culture medium per se had a significant higher 
level of testosterone production compared to the other culture media (F12, DMEM/F12, and 
MEM). The DMEM + glutamine culture medium contains higher levels of amino acids in 
comparison to the other culture media used, as stated by the supplier. By adding either AA or 
NEAA to F12 culture medium, the difference in testosterone production could not be 
compensated. 
The effect of adding glutamine or Glutamax, a substituent for glutamine, to the culture 
medium has been studied as well. When the DMEM + glutamine culture medium was 
compared to the DMEM – glutamine or DMEM + Glutamax culture media, DMEM + 
glutamine had a significantly higher level of testosterone production compared to the other 
two culture media after 24 hour of stimulation with gonadotropins. This difference 
disappeared after 7 and 14 days of culture. However, the DMEM + Glutamax culture medium 
had the highest testosterone production among the three culture media without any 
stimulation by gonadotropins for up to 14 days. 
4.2.2 Influence of the various culture media on the expression of 
steroidogenic genes by Leydig cells in a 3D culture system 
The qPCR technique was utilized to assess the effect of culture medium on the gene 
expression profile for the steroidogenic enzymes Star and Translocator Protein (Tspo). After 
24 hours of gonadotropins stimulation of the rat testicular cells in the 3D culture system, the 
DMEM + glutamine resulted in a significantly higher expression of Star compared to F12, 
F12 + AA, F12 + NEAA or DMEM/F12, and a significantly higher expression of Tspo 
compared to F12 + AA, DMEM/F12 or MEM. 
4.2.3 Medium-related effects on the differentiation of pre-pubertal rat male 
germ cells in vitro 
After culturing rat pre-pubertal testicular cells in 3D culture system using three culture media, 
DMEM + glutamine, DMEM + Glutamax and F12, the expression of six genes specific for 
germ cell differentiation was evaluated by qPCR. Using the DMEM + glutamine medium, the 
expression of Zbtb16 (also known as Promyelocytic Leukemia Zinc Finger; Plzf) was 
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significantly upregulated after 21 days of culture. On the other hand, Kit and Dazl were 
significantly downregulated after 21 days of culture using DMEM + glutamine or DMEM + 
Glutamax culture medium, while Crem was significantly downregulated after 21 days of 
culture using DMEM + glutamx medium. The expression of Boll or Protamine was not 
detected under any of the experimental conditions. 
4.2.4 Gonadotropins protect rat testicular cells in the different culture media 
from apoptosis 
The TUNEL assay was used to evaluate the effect of gonadotropins stimulation on apoptosis. 
Using three different culture media, DMEM + glutamine, DMEM + Glutamax, and F12, rat 
pre-pubertal testicular cells were cultured in a 3D culture system for 7 days, with or without 
gonadotropins stimulation. The results revealed that gonadotropins stimulation, compared to 
no stimulation at all, resulted in significantly less apoptotic cells (%) using DMEM + 
glutamine or DMEM + Glutamax culture medium. Moreover, when the three culture media 
were used without gonadotropins stimulation, the DMEM + glutamine culture medium had 
significantly less apoptotic cells (%) compared to DMEM + Glutamax or F12 culture 
medium, while there was no such difference when the three culture media were used with 
gonadotropins stimulation. 
4.2.5 Discussion 
Our group has previously used the 3D agarose culture system in producing post meiotic germ 
cells from mouse in vitro (480,481). Considering a few culture media were used earlier in the 
germ cell culture (489,531), the effect of choosing a specific culture medium has not been 
studied yet. Moreover, the important role of gonadotropins (hCG and FSH) and functional 
somatic environment of the testis (Leydig and Sertoli cells) in spermatogenesis has been well 
established (230,473,481,532). Hence, we wanted to exploit the 3D culture system, our group 
used previously in culturing murine testicular cells, to culture rat pre-pubertal testicular cells. 
Our aim was to investigate the optimal culture condition (choice of culture medium and 
gonadotropin stimulation) for germ cell maturation in vitro. Herein, we have studied the 
effect of culture medium and gonadotropins stimulation on Leydig cell functionality, as an 
important player in the somatic environment, by evaluating the testosterone production, and 
on the expression of steroidogenic enzymes and the genes related to germ cell differentiation. 
Moreover, the effect on cell viability in vitro has been studied as well. In that context, 
gonadotropins stimulation had a significant impact on cell survival, which has been reported 
earlier (237,533,534). The exact mechanism by which gonadotropins exert the anti-apoptotic 
effect is still unclear. However, the same effect on rat granulosa cells has been elucidated to 
be through the stimulation of a B-Cell CLL/Lymphoma 2 (Bcl2) anti-apoptotic family 
member protein Mcl-1 (535). 
Gonadotropins stimulation had a significant effect on testosterone production, which is 
expected. Nevertheless, the DMEM + glutamine culture medium had the most pronounced 
effect on testosterone production among the media tested, which indicates the importance of 
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glutamine to testosterone production. This positive effect of glutamine was exhibited by the 
upregulation of the steroidogenic enzymes Star and Tspo; both of which are important 
regulatory enzymes in testosterone synthesis, responsible for transferring cholesterol through 
the mitochondrial membrane (536-539). Glutamine, in general, is an important source of 
energy, as well as a precursor for protein biosynthesis (540-543), which could explain the 
positive effect, by stimulating the production of the essential enzymes in steroidogenesis. 
Glutamax, on the other hand, is a dipeptide of alanine-glutamine. This dipeptide is used to 
release glutamine over a long time of culture, so that the cells are not damaged by the high 
pH produced by glutamine decomposition in culture (544). Adding AA and NEAA to F12 
could not upregulate the steroidogenic enzymes or elevate the level of testosterone production 
to the level produced by the DMEM + glutamine medium, which could be a result of the 
difference in ingredients, other than the amino-acids, between the different culture media. 
The gene expression analysis for germ cell differentiation related genes revealed an overall 
downregulation of these genes, irrespective to the culture medium used, which indicates a 
non-robust system for germ cell differentiation in vitro. The qPCR results were confirmed by 
the morphologic and immunohistologic evaluation, which showed germ cells emerging from 
the colonies containing other testicular cells, with no differentiated germ cells could be 
observed. Thus there was no spatial support for the germ cells by Sertoli cells, as it is the case 
in vivo (532,545,546), which could explain the poor efficiency of the system. 
Taken together, the culture conditions (choice of culture medium per se) have an effect on the 
Leydig cell functionality, but not the germ cell differentiation in vitro using 3D culture 
conditions. Moreover, the germ cells are migrating outwards the colonies in the 3D culture, 
leading to unfavorable conditions for germ cell differentiation, as they lose contact with the 
Sertoli cells. 
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4.3 RAT GERM CELL MATURATION IN VITRO USING ORGAN CULTURE 
SYSTEM (PAPER III) 
The organ culture technique has been reported recently to support murine germ cell 
differentiation in vitro (489). Hence, we have exploited the same culture system to investigate 
the possibility of pre-pubertal rat male germ cells cultured for 52 days to differentiate in vitro, 
using different culture conditions; plain MEMα culture medium, with or without Glutamax, 
and with or without supplementation with melatonin and RA. Since Glutamax has shown a 
better cell viability profile in vitro than glutamine in the second study of the thesis, it was 
used in this third study of the thesis instead of glutamine. The effect of co-culture of the rat 
testicular tissue with epididymal fat was also investigated. In addition, germ cell 
differentiation has been assessed by immunohistologic and morphologic evaluation, as well 
as on the level of gene expression. 
4.3.1 Effect of culture medium on rat male germ cell proliferation in vitro 
When the rat pre-pubertal testicular tissue was cultured in an organ culture setup for 52 days 
in vitro, using MEMα culture medium with or without Glutamax, there was no significant 
difference between the two culture media regarding the proliferation index. This index was 
calculated as the percentage of tubules containing Ddx4-positive/Ki67-positive cells 
compared to the total number of tubules in a section. 
4.3.2 Rat male germ cell differentiation in vitro using organ culture system 
After staining the rat testicular tissues cultured for 52 day in vitro in the different conditions 
with PAS staining, the morphologic evaluation revealed the presence of cells exhibiting the 
morphologic characteristics of spermatocytes and round spermatids in the cultured tissues. 
However, there was no difference between the different culture conditions in the number (%) 
of the tubules containing differentiated germ cells. In order to confirm the morphologic 
observations, gene expression and protein expression of the genes related to germ cell 
differentiation were evaluated by qPCR and immunostaining respectively. 
4.3.2.1 Gene expression 
When the genes of interest (Acr, Crem, Prm1, Sycp3, Boll, Kit, Zbtb16, Dazl, and Ddx4) were 
investigated by qPCR, the results showed a slight overall upregulation for all of the genes in 
the cultured tissues compared to the control pre-pubertal tissues. However, this upregulation 
did not reach significance, due to the high variance between the biological replicates. One 
exception was Sycp3, where the plain medium without supplementation had a significant 
higher expression than the control pre-pubertal tissues. In addition, the adult (60 dpp) control 
testicular tissue showed a significant higher expression profile for all of the genes, except for 
Kit and Zbtb16, compared to the pre-pubertal tissues and the cultured tissues. As for Sycp3, 
the cultured tissue in the plain medium, with no supplementation, was not significantly 
different from the adult control testicular tissue. Finally, comparing the different culture 
conditions with each other resulted in no significant difference, except for the plain medium 
without supplementation, where Sycp3 was significantly upregulated. 
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4.3.2.2 Protein expression 
To investigate the protein expression, immunostaining for Crem and Acrosin was performed 
on the cultured tissues. The results showed the presence of cells positive for Crem and 
Acrosin in the cultured rat testicular tissues. The Crem positive cells had a uniform intensity 
profile; a strong nuclear Crem positive staining, while the Acrosin positive cells had either 
one of two intensity profiles; dim cytoplasmic or bright perinuclear. Interestingly, there was 
no significant difference between the different culture conditions in the number (%) of the 
tubules containing Crem positive or Acrosin positive (for any of the two intensity profiles) 
cells. However, when the two intensity profiles of Acrosin were pooled together, the plain 
non supplemented medium had a significant higher number (%) of tubules containing 
Acrosin positive cells compared to the other culture conditions. 
4.3.3 Functionality of rat Leydig and peritubular cells in vitro using organ 
culture system 
Evaluation of testosterone production was used as a functionality assessment for the rat 
Leydig cells cultured for up to 52 days in vitro. Thus, intra-testicular testosterone was 
extracted and evaluated using an ELISA kit specific for testosterone. The results showed that 
the testosterone production after 3 days of culture was significantly higher than the 
production after 10 and 52 days of culture. Moreover, when the different culture conditions 
were compared together, there was no significant difference between the different culture 
conditions, in regards to testosterone production, after culturing the rat testicular tissues for 
52 days in vitro in the different conditions. 
After 21 days of culture, the rat testicular tissues co-cultured with epididymal fat showed 
spontaneous contractility lasted till the end of the culture after 52 days, which indicates the 
functionality of the peritubular cells. This contractility was not observed in the rat testicular 
tissues cultured alone with no fat. However, this positive effect on PMCs was not translated 
to appositive effect on germ cell differentiation, as it was not observed. 
4.3.4 Discussion 
Recently, the first full in vitro maturation of murine male germ cells into functional gametes 
using the organ culture technique has been reported by Sato and colleagues (489). Since then, 
other researchers have reported similar achievements (495-497). As it could be of a great 
importance to translate this success into a clinical option, it is crucial to repeat the same 
success in other species. Hence, we have used here the rat model, as a step forward from the 
mouse model to clinics. Rats take for a full spermatogenesis in vivo a period of time that is 
longer than mice but shorter than humans (547). Moreover, they have a longer 
spermatogenesis recovery time after irradiation compared to mice, but still they have a 
shorter recovery period compared to humans (548). In addition, a recent trial to differentiate 
the rat male germ cells in vitro has been reported (549). However, in that study, the authors 
did not investigate the expression of post meiotic germ cell markers on protein level. Our 
group has used earlier the 3D culture system for rat and mouse male germ cell maturation in 
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vitro (480,550). However, the 3D culture system showed a very poor efficiency, due to the 
dis-orientation of the germ cells in relation to the Sertoli cells, as it was discussed previously 
in the second paper (section 4.2.5). Therefore, we have tried here to differentiate immature rat 
male germ cells in vitro, exploiting the organ culture technique used earlier by Sato, under 
different culture conditions, while focusing on the investigation of the post-meiotic markers; 
Crem and Acrosin, on protein level. 
In rats, Crem is expressed from the late pachytene spermatocyte stage to the released 
spermatid (247). Meanwhile, the Acr gene is transcribed in the diploid stage, but its 
translation to the Acrosin protein is suppressed till the post-meiotic haploid round spermatid 
stage (252,254). Then, Acrosin is expressed as an inactive zymogen (proacrosin), which is 
stored in the acrosome till fertilization (253). The usage of Crem and Acrosin as markers for 
post-meiotic germ cells has been reported earlier (480,489,490). Thus, we have investigated 
here the protein expression of Crem and Acrosin. Using immunostaining, Crem was found to 
be expressed in the nucleus, which is in accordance with what has been reported earlier (551). 
Meanwhile, two intensity profiles of Acrosin have been noticed; dim cytoplasmic and bright 
perinuclear, in contrast with the previous reports, where the Acrosin expression was only 
bright perinuclear (252,254). However, it has been reported earlier in mice that Acrosin has a 
faint cytoplasmic expression in the pachytene spermatocyte stage, followed by condensation 
of the Acrosin in the post-meiotic haploid stage in the acrosome to give a bright perinuclear 
expression (552). Consequently, we have proposed that Acrosin in rats first expressed faintly 
in the cytoplasm in the late pachytene spermatocyte stage, followed by concentration of the 
Acrosin in the acrosome in the post-meiotic haploid stage. 
The rat testicular tissues were cultured for 52 days, which represents the time needed for full 
spermatogenesis in vivo for rats (269,553), whereas the plain culture medium used here was 
MEMα + 10% KSR; the optimal culture medium used by Sato and colleagues previously 
(489). Indeed, we have confirmed the possibility of immature rat male germ cell 
differentiation in vitro using the organ culture system. However, we have noticed that the 
efficiency of the organ culture system in rat male germ cell differentiation in vitro into post-
meiotic cells was very low, compared to the efficiency of the same system in mouse (497). 
This differentiation was confirmed by the gene expression analysis, which showed an overall 
upregulation of the genes related to germ cell differentiation after 52 days of culture. The 
upregulation of these genes did not reach significance, due to the scarcity of the differentiated 
cells. 
In order to optimize the culture conditions for rat germ cell differentiation in vitro, we 
intended to add different supplements to the culture medium; Glutamax, melatonin and RA. 
Glutamax was shown earlier to have a positive effect on cell viability (550). Meanwhile, 
melatonin, which is produced mainly by the pineal gland (but also by the testis) (554), has an 
anti-cytotoxic effect, through scavenging the reactive oxygen species (ROS) (555-562). In 
addition to being essential for germ cell differentiation in vivo (563-569), RA was also shown 
to have a positive effect on stem cell differentiation towards male germ cell in vitro (570,571) 
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and on the male germ cell differentiation in vitro (478,572). Unfortunately, none of the 
previous supplements could improve the efficiency of the organ culture system in 
differentiating the rat male germ cells in vitro, which is consistent with what Sato and 
colleagues have reported previously, that DMEM + 10% KSR was enough to differentiate the 
mouse male germ cells in vitro (489). In the same context, epididymal fat was co-cultured 
with the rat testicular tissue to improve the efficiency of the culture system, as it was reported 
earlier to be important for spermatogenesis (573,574). However, no positive effect for the 
epididymal fat on germ cell differentiation in vitro. In addition, no positive effect on 
testosterone production could be observed, which matches with what has been reported 
earlier (574). On the other hand, epididymal fat did stimulate the PMCs to show spontaneous 
contractility. 
Taken together, rat undifferentiated spermatogonia could be differentiated in vitro to round 
spermatids showing Acrosin and Crem on protein level as post-meiotic markers, using the 
organ culture conditions previously described for murine germ cell differentiation in vitro. 
However, the supplementation with melatonin, RA, or Glutamax did not enhance the germ 
cell differentiation in vitro. 
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4.4 HUMAN PRE-PUBERTAL TESTICULAR ORGAN CULTURE (PAPER IV) 
Maturation of human male germ cells in vitro turned to be of a great importance to solve 
various male infertility problems. One of the compelling indications is young boys 
undergoing gonadotoxic therapy, as they do not have sperm that can be cryopreserved for 
later use (325,367). Recently, Sato and colleagues reported for the first time a full mouse 
spermatogenesis in vitro, using an organ culture system (489). This was followed by us 
showing the differentiation of rat germ cells in vitro to round spermatids, using the same 
organ culture system. Hence, we aimed in this study at culturing for long term (91 days) 
human pre-pubertal testicular tissue in vitro, taken from patients undergoing gonadotoxic 
therapy, using an organ culture system and different culture conditions (Nutristem and 10% 
KSR-xf supplemented with different combinations of RA, SCF, rFSH, melatonin, and 
testosterone). The ultimate goal was to establish a robust protocol to differentiate the human 
immature male germ cells in vitro. 
4.4.1 Effect of size of the cultured tissue on the necrotic area 
When human testicular tissues were cultured in vitro using an organ culture system, they 
showed a characteristic pattern of a central necrotic region and a peripheral healthier ring. 
The surface area of the necrotic region was measured by ImageJ software and the percentage 
of this area to the total surface area of the tissue section was calculated.  
By comparing the necrotic area (%) of the tissue sections between the different culture 
conditions and different time points, there was no significant difference due to the different 
culture conditions or due to the period of culture, although there was a trend of increased 
necrotic area (%) after 77 days of culture in all culture conditions. However, there was a clear 
trend of increased necrotic area (%) as the radius of the tissue piece decreased less than 300 
µm, irrespective to the culture condition or the period of culture. 
4.4.2 Viability and functionality of Sertoli cells and Leydig cells in vitro using 
organ culture system 
Functional somatic environment (Sertoli and Leydig cells) are crucial for germ cell 
differentiation. Hence, investigating the viability and functionality of these cells is of great 
importance to establish an in vitro system for germ cell differentiation. Testosterone and 
inhibin B production in the culture medium was used to assess the viability and functionality 
of Leydig and Sertoli cells in vitro respectively. Evaluation of the testosterone produced 
revealed an age-dependent pattern, in which the patients with less than one year of age 
showed a constant testosterone level for up to 91 days of culture, whereas the patients with 2-
11 years of age showed a decline in testosterone production after 42 days of culture.  
On the other hand, evaluation of inhibin B showed that all the cultured tissues were 
producing inhibin B in the first three weeks of culture, with a trend for increased production 
after 2 weeks of culture. However, there was no specific age-dependent pattern of inhibin B 
production. Both results indicated the viability and functionality of the Leydig cells and 
Sertoli cells cultured in vitro. 
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4.4.3 Sertoli cell maturation in vitro using organ culture system 
Morphologic evaluation of the human testicular tissues cultured in vitro revealed a tubular 
growth after 7 days of culture. Moreover, this evaluation showed morphologic changes in 
Sertoli cells cultured in vitro characteristic to Sertoli cell maturation (elongation of cell 
nuclei, cell migration to the basal membrane and polarization of these cells). 
In addition to the morphologic evaluation, immunostaining for the Sertoli cell marker SOX9 
revealed that at the beginning of the culture, the tissues had mainly nuclear SOX9 staining. 
While for the cultured tissues, SOX9 expression could be detected in the cytoplasm of Sertoli 
cells in the majority of the cultured tissues after 91 days in culture. On the other hand, the 
evaluation of WT-1 expression by immunostaining, another Sertoli cell marker, showed a 
nuclear staining in the beginning of the culture, whereas the cultured tissues showed a 
condensed nuclear staining after 91 days in culture. 
The germ cell marker, DDX4, could be detected in beginning of culture in most of the 
patients. However, after 42 days of culture, it could not be detected. 
4.4.4 Discussion 
Anti-cancer therapies that imply high risk for gonadotoxicity can cause male infertility to the 
surviving patients. Since the survival rate after cancer therapy is improving dramatically in 
the recent years, fertility preservation is getting more attention. For adult male patients, sperm 
cryopreservation forms a straightforward simple clinical option. However, young cancer 
survivors do not have such option, as they cannot produce sperm before puberty. Fertility 
preservation options for such patients are all experimental till now. These options include 
autologous SSCs transplantation, xeno-transplantation and in vitro germ cell maturation. 
Among these techniques, in vitro maturation of germ cells represents one the most promising 
clinical options. So far, in vitro maturation of mouse male germ cells (489) and rat male germ 
cells (in paper III in this thesis) has been reported, using an organ culture system. Hence, in 
this study, we used testicular tissues from 12 pre-pubertal patients, before or during 
undergoing therapy with high risk for gonadotoxicity, for a long term culture, using an organ 
culture system. 
Evaluation of DDX4, the germ cell marker, showed that 91% of the patient had germ cells in 
the beginning of the culture, indicating that the therapy did not eliminate all of the germ cells 
in the seminiferous tubules. However, germ cells could not be detected after 42 days in 
culture. This could be due to negative impact of a previous gonadotoxic treatment, as some of 
the patients have had already earlier treatment, or due to the negative impact of the 
underlying disease itself. It has been reported that some malignancies might cause abnormal 
germ cell maturation (358). 
Meanwhile, evaluation of the Sertoli cell marker, SOX9, showed a change in the expression 
pattern form nuclear to cytoplasmic after culturing in vitro. SOX9 is expressed from the 
immature Sertoli cell stage. It starts as a cytoplasmic expression in the pre-Sertoli cells, and 
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then, SOX9 relocates to the nucleus at 6.5 weeks of gestational age. Thus, this expression 
pattern could indicate de-differentiation of the Sertoli cells in vitro, which is in contrast with 
the morphologic changes we have observed. De-differentiation of adult mature Sertoli cells 
have been reported previously (575). However, the de-differentiation of immature Sertoli 
cells towards pre-Sertoli cells has not been studied before, which makes it interesting to 
investigate this issue. 
Functionality of Leydig cells and Sertoli cells was evaluated by estimating the testosterone 
and inhibin B production respectively. The levels of testosterone produced in the culture 
could not be related to the diagnoses included in the study, or even to the culture conditions 
used. However, a tendency to cease producing testosterone was after around 42 days of 
culture, which indicates the deceased viability and functionality of Leydig cells in vitro after 
42 days. Since testosterone is crucial for spermatogenesis (307), this result suggests the 
importance of adding exogenous testosterone to the culture after 42 days. However, the age 
of the patient had an impact on the sustainability of testosterone production, as the young 
patients (less than one year of age) had a constant testosterone level till 91 days of culture. 
This is in accordance with the fact that Leydig cells in the neonatal age recruit more precursor 
cells and are more sensitive for hormonal stimulation (576). Inhibin B was also detected in 
the culture medium, which suggests the functionality of Sertoli cells as well. Both Leydig and 
Sertoli cells (the somatic environment) are crucial for achieving full spermatogenesis. Thus, 
we assume that the culture conditions were sufficient to support the viability and functionality 
of the somatic cell environment, which should facilitate germ cell differentiation. 
Taken together, the Leydig cells and Sertoli cells showed viability and functionality after 42 
days and 21 days respectively of culturing testicular tissue of pre-pubertal testicular tissue in 
vitro for 91 days using an organ culture system. However, after 91 days of culture, no germ 
cells could be detected. 
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5 CONCLUSIONS 
 
In this thesis, we have assessed the effect of culture conditions on the differentiation potential 
of hES cells towards male germ cells in vitro. Moreover, we have established a protocol for 
differentiating immature rat male germ cells in vitro. In addition, we have also studied the 
effect of long term culture of human pre-pubertal testicular tissue in vitro. The main findings 
in the thesis are: 
 Undifferentiated hES cell lines exhibit different gene expression profiles. In addition, 
the same hES cell line could have different gene expression profiles under different 
culture conditions. 
 The suspension culture method for hES cells resulted in an improved differentiation 
profile, in regrads to the downregulation of the pluripotency markers NANOG and 
POU5F1, compared to the well-known culture method on hFFs feeders. 
 BMP7 stimulation of the HS360 hES cell line during differentiation resulted in an 
upregulation in the germ cell markers KIT and DDX4 and somatic cell markers FSHR 
and HS3BD1, with a downregulation in the pluripotency markers NANOG and 
POU5F1. 
 Choice of medium and culture conditions for rat testicular cell culture in vitro in a 3D 
culture system has an effect on the Leydig cell functionality, but not on germ cell 
differentiation. 
 Rat male germ cells are migrating towards the outside of the colonies, which contain 
somatic cells, in a 3D culture system in vitro, which makes it unfavorable for germ 
cell differentiation. 
 Differentatition of rat undifferentiated spermatogonia (pre-meiotic) into round 
spermatids expressing Crem and Acrosin (post-meiotic) in vitro could be obtained, 
using an organ culture system and MEMα + 10% KSR culture medium, previously 
described for the mouse. Meanwhile, supplementing the culture medium with 
melatonin, RA or Glutamax, or co-culturing with epididymal fat did not enhace the 
rat male germ cell differentiation in vitro. 
 Culturing human pre-pubertal testicular tissue in vitro using an organ culture system 
for a long term showed viability and functionality of Leydig cells and Sertoli cells for 
up to 42 days and 21 days respectively. However, no germ cells could be detected at 
91 days of culture. 
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6 CRITICAL EVALUATION AND FUTURE PERSPECTIVES 
Indeed, finding a clinical option for fertility preservation for young cancer survivors, as well 
as young survivors from other conditions necessitating gonadotoxic treatment, is an 
intriguing question. Although the survival rate is improving a lot in the recent years, still the 
fertility preservation options for those survivors did not develop too much. Hence, we tried 
here in this thesis to get more insights about male germ cell differentiation in vitro, as one of 
the most promising alternatives of fertility preservation. 
We have investigated the differentiation potential of three hES cell lines towards male germ 
cells in vitro. Our results showed that the choice of the cell line and the culture condition 
could affect the differentiation potential. An upregulated germ cell markers expression, along 
with downregulated mesoderm, endoderm and ectoderm markers expression might predict 
the fate of the undifferentiated hES cells towards male germ cells. However, we should also 
state that these results are based on studying three hES cell lines only, which could be not 
sufficient to make a final judgement. Furthermore, finding the NODAL/ACTIVIN pathway 
relatively unchanged in the cell line suspected to differentiate towards male germ cells is a 
real point of interest. Further studies are needed to elucidate the role of this pathway in 
differentiation of hES cells in vitro towards germ cells. Taken together, the study is paving 
the way for further studies on hES cell differentiation potential towards male germ cells. 
However, the results should be cautiously interpreted, since we have to characterize more the 
differentiated cells to confirm that they are gonadal cells, and we have to investigate larger 
number of hES cell lines to make sure that the culture conditions, along with the gene 
expression profile, can be used robustly to predict the differentiation potential of the hES 
cells. 
In addition, we have also studied the effect of the culture conditions on differentiating rat pre-
pubertal testicular cell culture in vitro using a 3D culture system. The results showed that the 
culture medium per se can affect the functionality of Leydig cells in vitro in a 3D culture 
system, while it has no effect on germ cell differentiation. In fact, this study was initiated 
before we start using the MEMα culture medium in culturing testicular tissues in vitro. 
Therefore, it would be of great importance to study larger number of culture media, including 
the MEMα culture medium, in a further study to get a better conclusion. Moreover, the effect 
of glutamine on the steroidogenic enzymes, albeit proven, needs to be studied carefully to get 
insights about the mechanism behind this effect. The study also showed that the 3D culture 
system is not an optimal option for germ cell differentiation in vitro, due to the dis-
arrangement of the germ cells in regards to the Sertoli cells in culture. This point is really 
interesting, and needs further studies to investigate the exact effect of germ cell positioning, 
in regards to Sertoli cell, on germ cell differentiation in vitro. 
Using the organ culture system previously published for murine male germ maturation in 
vitro, we could show the differentiation of undifferentiated rat spermatogonia to post-meiotic 
round spermatids, expressing Crem and Acrosin on protein level. In fact, the rat model is 
considered a step forward between the mouse model and human, which could be seen as 
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unique achievement. However, the efficiency of the culture system to produce post-meiotic 
germ cells was extremely low, even when compared to the mouse model. This makes it 
important to go further in studies for optimizing the organ culture system for rat germ cell 
maturation in vitro. Moreover, the integrity of the post-meiotic cells produced by this system, 
along with the functionality, should be further assessed. Indeed, supplementation of the 
culture system with different supplements, we speculated its positive effect on the culture, 
could not improve the rat germ cell differentiation in vitro. However, more studies should 
follow, in order to evaluate the effect of these supplements thoroughly. Other supplements 
should be searched for, proposed and investigated as well, in order to optimize the organ 
culture system. In addition, the rat model is still not physiologically identical to humans, 
which makes further studies on human testicular organ culture in vitro inevitable. 
Unequivocally, translating the achievements that we have reached into a clinical option for 
patients is our ultimate goal. Hence, we investigated in this thesis the possibility of 
differentiating human pre-pubertal immature germ cells in vitro, using the organ culture 
system. We have considered the different time periods needed by the different species in 
order to achieve a full spermatogenesis in vivo to be representative for the time needed in 
vitro to achieve the same. Knowing that human spermatogenesis in vivo is the longest among 
the three species (mouse, rat and human); we expected that that human immature testicular 
tissue should spend longer time in culture in order to get mature germ cells. Hence, we 
studied here the effect of the long term culture on the human pre-pubertal testicular tissue. 
However, the study has still a lot of ongoing investigation. For instance, inhibin B evaluation 
needs to be performed on the samples from time points up to 91 days in culture, in order to 
give a clearer picture about Sertoli cell functionality. In addition, characterization of Sertoli 
cells in the culture will give us an insight about the stage of maturation they have reached in 
vitro. This is of great importance, as having mature Sertoli cells is crucial to differentiate 
germ cells using the organ culture approach. Besides, the evaluation of germ cell 
development in vitro needs to be more clarified, using markers for the different stages of 
development of human male germ cells. Assessing the proliferation potential of the testicular 
cells in vitro is also a privilege, as it will assist in defining the maturation stage of both germ 
and Sertoli cells. Furthermore, we are planning to investigate the effect of adding different 
supplements, suspected to be beneficial, to the culture medium on the human male germ cell 
differentiation in vitro. Other methods of evaluation (e.g. qPCR and RNA sequencing for 
gene expression analysis and Western blotting for protein expression) should be also 
included, in order to confirm the results obtained so far. Therefore, this study is giving 
insights about the effects of long term culture on human pre-pubertal testicular tissue, which 
facilitates further studies towards the ultimate goal of achieving full human spermatogenesis 
in vitro. 
In conclusion, this thesis provides new insights about male germ cell differentiation in vitro, 
in rat and human. However, further investigations are still needed in order to translate such 
insights into a clinical option.  
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